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CORTICOTROPIN RELEASING FACTOR RECEPTORS AND AGONISTIC BEHAVIOR
IN SYRIAN HAMSTERS
by
ALICIA N. FARUZZI
Under the Direction of Kim L. Huhman, PhD
ABSTRACT
Social conflict is a part of everyday life, and it can be a potent stressor for both
humans and other animals. In the laboratory, when two Syrian hamsters (Mesocricetus
auratus) compete for territory, a dominance hierarchy is quickly formed. Becoming
subordinate is a significant stressor resulting in increased release of adrenocorticotropic
hormone, β-endorphin, and cortisol. Defeated hamsters will also subsequently fail to display
territorial aggression in future social encounters and will instead display increased
submissive behavior, even in the presence of a smaller, non-aggressive intruder. This change
in behavior is consistent and long-lasting and has been termed conditioned defeat (CD).
Corticotropin releasing factor (CRF) is an important neuropeptide in the control of the
hypothalamo-pituitary-adrenal (HPA) axis response to stress. It is also involved in a number
of behaviors such as anxiety, stress responding, food intake, learning, and memory. The
widespread distribution of CRF, CRF-like peptides, and CRF receptors, particularly in brain
sites related to anxiety, fear, and stress responses, suggests a role for CRF and CRF-like
peptides in modulating emotional responses other than via HPA axis activity.
It has also been shown that CRF may have a role in the acquisition and expression of
CD. Non-specific and CRF type 2-specific CRF antagonists reduce the acquisition and
expression of CD in male hamsters while injection of a CRF type 1-specific antagonist does

not. Therefore, the goal of this dissertation was to investigate the role of CRF type 1 and 2
receptors in CD in hamsters and to identify neuroanatomical locations where CRF may be
acting. It was found that non-specific or CRF type 1 receptor specific agonists enhance the
expression, but not acquisition, of CD. Further, these agonists appear to enhance aggressive
behavior in animals that were not previously defeated, suggesting a modulatory role for CRF
type 1 receptors in agonistic behavior that depends on an animal’s previous social
experience. Further, localization of CRF receptors was determined in hamster brain in sites
thought important for CD and agonistic behavior, but changes in receptor binding following
defeat were not observed. Implications of these results and future directions are discussed.
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INTRODUCTION
This dissertation examines the role of corticotropin releasing factor receptors in
agonistic behavior and in conditioned defeat in Syrian hamsters. Data from a number of
research areas including stress, anxiety, conditioned and unconditioned fear, aggression, and
defense are relevant to this topic. These areas are reviewed briefly in the following sections.
Background material necessary for an understanding of corticotropin releasing factor and its
receptors, both on a molecular level and as a modulator of behavior, are also presented.
Stress
Stress is the nonspecific response of the body to any demand, particularly one that is
noxious (Selye, 1998). The body has a given set of responses that it uses to deal with various
stressors, and prolonged or severe stress can cause illness (Selye, 1979). Stressful life events
are linked to an increased chance of developing several psychological disorders, including
affective or anxiety disorders (Holsboer, 1988; Barden, 1996; Plotsky et al., 1998; Mitchell,
1998; Arborelius et al., 1999).
Numerous animal models have been utilized to study stress, such as restraint, foot
shock and forced swim. However, many of these models use physical, sometimes painful,
stimuli to evoke stress. Although these studies have provided important insights into the
physiological basis of stress, they may not be considered ethologically valid models of
psychological stress. For example, foot shock is not a stressor that an animal is likely to
encounter in the wild, thus it may elicit a stress response that is much stronger than would be
elicited in response to a more naturalistic stressor. In contrast, a more relevant stressor, such
as social conflict or predation, which an animal might encounter in the wild, may elicit a
more natural stress response. Some
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current, more ethologically valid models of stress include features like maternal deprivation
(Arborelius et al., 1999; Lehmann et al., 1999; Hsu et al., 2003; Romeo et al., 2003; Vazquez
et al., 2003) or social interaction or conflict (Korte et al., 1990; Haller et al., 1996; Blanchard
et al., 2001; Cacho et al., 2003; Summers et al., 2003).
Social conflict is necessary for the development of social relationships in many
species, both human and non-human. When conflict arises, the outcome (i.e., whether the
individual “wins” or “loses”) may have a strong and lasting impact. Animals can encounter
social conflict in such contexts as competition for food or access to females or territories.
Results of being defeated during an agonistic encounter can include increased heart rate,
elevated blood pressure, and suppressed immune function (Bohus et al., 1993; Blanchard et
al., 1995; Meehan et al., 1995), as well as activation of the HPA axis and behavioral changes
like decreased reproductive, exploratory, or aggressive behavior, decreased food and water
intake, and increased anxiety (Heinrichs et al., 1992; Potegal et al., 1993; Rodgers and Cole,
1993; Albonetti and Farabollini, 1994).
Conditioned and Unconditioned Fear
There has been extensive research investigating the neuroanatomy of fear, the control
of which appears to lie in the amygdala or BST. Several subnuclei of the amygdala appear to
be critical components of the circuitry in the brain responsible for the acquisition and the
expression of conditioned fear (Davis, 1997). The BLA receives information from cortical
areas involved in processing sensory input. The BLA projects to the Ce which then projects
to sites in the hypothalamus and brain stem that are responsible for mediating physiological
and behavioral responses to stressors. Some of these nuclei and their corresponding
functions include the lateral hypothalamus (activation of the sympathetic nervous system),
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the paraventricular nucleus (glucocorticoid release), the ventral tegmental area, locus
coeruleus and basal forebrain (increased attention and vigilance), and the PAG (freezing or
fleeing). The amygdala also shares reciprocal projections with the BST, forming what is
sometimes referred to as the extended amygdala (McDonald, 2003).
Whereas the Ce is responsible for controlling conditioned fear responses via its
projections to the hypothalamus and brainstem, the BST, or more specifically the lateral BST
(BSTL), appears to be more involved in controlling the various physiological and behavioral
responses to unconditioned fearful stimuli (Walker and Davis, 1997; Davis, 1997; Lang et
al., 2000). The BSTL receives input from the BLA and has similar outputs as the Ce (Davis
and Shi, 1999). Lesions of the BST block unconditioned fear responses in models such as
light- or CRF-enhanced startle in rats but do not block fear-potentiated startle, a measure of
conditioned fear. Conversely, lesions of the Ce block fear-potentiated startle but not light- or
CRF-enhanced startle. Finally, inactivation of the BLA attenuates both types of fear
responses. These findings have supported the hypothesis that there are two central fear
circuits, one for conditioned fear that is mediated by the Ce and one for unconditioned fear
that is mediated by the BSTL (Walker and Davis, 1997; Davis and Shi, 1999).
The Neurobiology of Agonistic Behavior
Agonistic behavior refers to the profile of behaviors exhibited during social conflict.
It includes aggressive behaviors, such as threat, attack, and pursuit, as well as defensive and
submissive behaviors such as defensive postures and flight (Albers et al., 2002). Social
communication is another aspect of agonistic behavior, but the neurobiology of
communicative behavior will not be discussed here.
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There are similarities and differences in the neural correlates controlling aggressive
and defensive behavior. The hypothalamus appears to lie at the center of either system
(Delville et al., 2000; Canteras, 2002). In the control of offensive aggression, the AH
receives olfactory and vomeronasal inputs from the amygdala (Me) and BST, as well as
somatosensory inputs from the PAG and autonomic inputs from the parabrachial nucleus
(Delville et al., 2000). These sites, as well as the LS, share reciprocal connections with the
AH, and some of them show Fos activation following bouts of offensive aggression
(particularly Me, BST, and PAG, and, of course, the AH). The VLH also shows Fos
activation and shares reciprocal connections with the AH, and stimulation of the VLH elicits
offensive aggressive behaviors (Delville et al., 2000).
The AH and the VMH are also important components of what Canteras (2002) refers
to as the medial hypothalamic defense system, or MHZ. Further, many of the same inputs
important for aggressive behavior are involved in the control of defensive behavior, and most
of these sites also show neuronal activation following social defeat (Kollack-Walker and
Newman, 1995; Kollack-Walker et al., 1997; Martinez et al., 1998; Martinez et al., 2002).
For example, the AH and VMHM receive inputs from the amygdala and BST that convey
sensory information necessary to trigger innate defensive responses, while the parabrachial
nucleus conveys information to the AH and VMHM about noxious stimuli (Canteras, 2002).
The role of the LS is likely similar in both offensive and defensive behavior. Specifically,
the LS appears to exert inhibitory control over the initiation of aggressive behavior from the
AH (Canteras, 2002). While this reciprocal pathway may be more important for receiving
feedback during offensive behavior (Delville et al., 2000), it would be important to have a
direct pathway for inhibiting aggression when defensive behavior is the appropriate response.
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Thus, the LS may act as a “switch,” turning attack on during offensive aggression or turning
it off to allow for defense.
Most outputs of the MHZ are to the same regions from where the inputs originate,
likely forming feedback loops (with the LS, amygdala, and BST, specifically). However, the
VMHM projects to the PAG to organize defensive responses. Additionally, the AH and
VMHM both project to the dorsomedial hypothalamus, which coordinates behavioral,
autonomic, and endocrine responses to acute stress (Canteras, 2002). At this point, defensive
and aggressive control differs greatly, because the stress response is an important element of
defensive behavior. Activation is seen in key sites involved in the stress response following
acute defeat (Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997; Martinez et
al., 1998; Martinez et al., 2002), making stress circuitry a critical component of the
neurocircuitry controlling defensive behavior.
Corticotropin Releasing Factor and its Receptors
CRF is a 41-amino acid peptide (Vale et al., 1983) located in the anterior pituitary
and throughout the brain (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002).
There are a number of peptides in the CRF family (see below), and they are involved in a
range of behaviors such as anxiety, stress responding, food intake, and learning/memory
(Eckart et al., 1999; Reyes et al., 2001; Grammatopoulos and Chrousos, 2002). There are
currently two known receptors in the CRF family. CRFR1 has one functional splice variant
and CRFR2 has three functional splice variants (CRFR2α,2β,2γ) (Dautzenberg and Hauger,
2002; Eckart et al., 2002). Both receptors are primarily Gs protein-coupled and they activate
adenylyl cyclase to increase cyclic AMP levels, though they are also associated with other
signaling pathways (Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos
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and Chrousos, 2002). CRFR1 is found throughout the brain in areas important for sensory
information processing and motor control, while CRFR2 is more restricted to subcortical
regions (Reul and Holsboer, 2002). CRFR1 mRNA has been found in sites including the
anterior pituitary, cerebral cortex, cerebellum, amygdala, hippocampal formation,
hypothalamus, areas of the brain stem, septum, BST, and olfactory bulb. CRFR2 mRNA has
been found in areas including the hippocampal formation, amygdala, LS, BST and areas of
the hypothalamus and brainstem (Eckart et al., 1999; Bittencourt and Sawchenko, 2000;
Dautzenberg and Hauger, 2002). Binding of agonists to CRFR1 causes HPA axis activation,
increased anxiety, increased depression, decreased feeding, and decreased inflammatory
response; binding of agonists to CRFR2 causes decreased feeding, decreased gastric
emptying, decreased depression (except when administered into the LS), increased
vasodilation, and decreased blood pressure (Holsboer, 1999; Steckler and Holsboer, 1999;
Arborelius et al., 1999; Eckart et al., 1999; Koob and Heinrichs, 1999; Takahashi, 2001;
Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).
The role that CRFR2 plays in anxiety and stress is not well understood. Some studies and
reviews report anxiolytic responses to CRFR2 activation (Eckart et al., 1999; Hashimoto et
al., 2001; Dautzenberg and Hauger, 2002; Pelleymounter et al., 2002), while other studies
report anxiolytic responses with antagonism of CRFR2 (Takahashi et al., 2001) or suggest
that CRFR2 activity can produce anxiogenic or anxiolytic properties depending on when
testing occurs or where in the brain the receptors are activated (Reul and Holsboer, 2002). It
has also been suggested that CRFR2 may have actions that oppose or modulate responses
mediated through CRFR1 (Reyes et al., 2001; Grammatopoulos and Chrousos, 2002).
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CRF, the first of its peptide family to be discovered (Vale et al., 1983), has many
behavioral and physiological effects. In addition to increasing anxiety-like responses,
arousal, and HPA axis activation, numerous studies demonstrate extrahypothalamic actions
of CRF in various fear conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et
al., 1999b; Takahashi, 2001) and in learning and memory tasks such as visual discrimination,
spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg
and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002). Urocortin is
the second endogenous peptide in the CRF ligand family to be discovered in mammals. It
gets its name from the fish CRF-like peptide urotensin I (hence “uro” - 63% sequence
similarity) and mammalian CRF (hence “cort” from corticotropin - 45% similarity) (Koob
and Heinrichs, 1999), and it has behavioral effects similar to those of CRF (Eckart et al.,
1999). In the brain, CRF mRNA can be found in the anterior commisure, hypothalamus
(median eminence, Pa, and periventricular nucleus in high concentrations), the limbic system
(including the amygdala with high concentrations in the central (Ce) and cortical nuclei,
BST, medial and lateral septum, and low concentrations in the hippocampus), and some
brainstem nuclei (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002). UCNimmunoreactivity can be found in the LS and hypothalamus (including low concentrations in
the Pa and supraoptic nucleus) (Eckart et al., 1999; Eckart et al., 2002; Reul and Holsboer,
2002). CRF (rat/human, r/h, and ovine, o) and UCN bind with high affinity to CRFR1, and
r/hCRF and UCN will both bind to CRFR2 with equal or less affinity than to CRFR1
(Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002;
Reul and Holsboer, 2002).
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A third member of the CRF ligand family, urocortin II (UCNII), shows high affinity
for the CRFR2 receptor and little affinity for CRFR1 (Reyes et al., 2001; Dautzenberg and
Hauger, 2002). It is distributed primarily in subcortical areas such as the Pa, supraoptic and
arcuate nuclei of the hypothalamus, locus coeruleus (LC), and some motor nuclei of the
brainstem (Reyes et al., 2001; Eckart et al., 2002; Reul and Holsboer, 2002). Administration
of UCNII causes Fos activation in the BST, Ce, Pa, parabrachial nucleus, and nucleus of the
solitary tract. UCNII causes suppression of food intake (Reyes et al., 2001), and some
studies report anxiolytic effects of UCNII administration (Valdez et al., 2002). As is the case
with CRFR2 receptors, the role that UCNII plays in anxiety and stress is still not completely
understood. Urocortin III (UCNIII), the most recently discovered mammalian ligand in the
CRF family, is 40% homologous to UCNII and is distantly related to r/hCRF and human or
mouse UCN. It displays lower affinity for CRFR2 than does UCNII and has no affinity for
CRFR1 (Lewis et al., 2001). UCNIII mRNA expression can be found in the AH, LH, LS,
BST, the medial amygdala, and in some brainstem nuclei (Lewis et al., 2001; Eckart et al.,
2002; Reul and Holsboer, 2002). Because of its distribution in brain sites associated with
stress-responding, it is likely that UCNIII is involved in controlling behavioral and endocrine
responses to stress (Lewis et al., 2001). Discovery of these specific ligands for CRFR1 and
CRFR2 has provided an opportunity to pharmacologically differentiate the roles of each
receptor subtype in various behaviors.
Corticotropin Releasing Factor and Stress
There are numerous examples of stress-induced changes in CRF peptide or
immunoreactivity. Acute stress decreases CRF in the median eminence and increases CRF in
the LC, BST, and Pa (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998; Hsu et al.,
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1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001). Stress-induced changes
in CRF occur in the Ce, as well, though the type of stressor used may affect whether CRF
increases or decreases post-stress (Hsu et al., 1998). An increase in Ce CRF has been seen
following acute restraint stress or footshock (Watts, 1996; Hsu et al., 1998), but some studies
using different types of stressors, such as osmotic stimulation or repeated restraint stress,
have observed decreases (Watts, 1992) or no change, respectively, (Hatalski et al., 1998) in
Ce CRF post-stress. Stress can also affect how a CRF agonist modulates behavior. CRF or
UCN has activational effects on behavior such as exploration in a non-stressful environment
(like a familiar environment) but has suppressive effects on locomotor or exploratory
behavior in a stressful environment (like a novel environment) (Koob and Heinrichs, 1999).
Finally, stress has been reported to affect CRFR density and binding. Chronic social stress in
tree shrews downregulates CRFR1 in brain regions involved in HPA axis control.
Additionally, CRFR1 was upregulated in areas including the Cg, Ce, and La, though binding
affinity was reduced in some of these areas (Fuchs and Flugge, 1995).
The time course for stress-induced changes in CRF can vary depending on the
location in the brain where the changes are occurring. Changes can take place in minutes or
not for hours. For example, CRF transcription increases in the Pa within about 5 minutes
post-stress (Kovacs and Sawchenko, 1996). Further, changes in Pa CRF are usually only
detectible immediately post-stress; however, changes in thalamic CRF can be seen 3 hours
after restraint stress but not immediately afterwards (Hsu et al., 2001). In other words, CRF
transcription occurs quickly in brain regions involved in immediate responses to stress (like
in the Pa to activate the HPA axis), while changes related to other functions (such as the
modulation of learning and memory) may occur more slowly.
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Corticotropin Releasing Factor as a Modulator of Fear and Anxiety
There are numerous studies demonstrating extrahypothalamic actions of CRF in
various fear conditioning paradigms. For example, blockade of CRFR1 in rats reduces
conditioned freezing, blocks fear potentiated startle, and decreases conditioned ultrasonic
vocalizations (Steckler and Holsboer, 1999; Takahashi, 2001). It has also been demonstrated
that three different CRF peptides (r/hCRF, oCRF, and rat UCN) dose-dependently enhance
both tone- and context-fear conditioning in mice (Radulovic et al., 1999b). However, there
are exceptions to CRF’s enhancing effects on fear conditioning. For example, unlike the
results seen by Radulovic, et al. (Radulovic et al., 1999b) with CRF peptides, transgenic
overproduction of CRF in mice does not affect context-dependent conditioning to a shock,
suggesting that different types of fear conditioning may be differentially modulated by CRF
(van Gaalen et al., 2002).
CRF is well-documented as a modulator of anxiety. CRFR1 antagonists reduce
anxiety-like responses in tests such as CRF-induced startle, elevated plus maze, defensive
withdrawal, and light-dark box exploration (Takahashi, 2001). Additionally, urocortin
increases anxiety-like behavior in the social interaction test, an effect that is blocked by
administration of the CRFR1 antagonist NBI3b1996 (Gehlert et al., 2005). Further, mice
overproducing CRF show increased anxiety-like behavior in the light-dark box test (van
Gaalen et al., 2002). CRF has also been shown to increase anxiety-like responses in CRFpotentiated startle via the BST, which, as described earlier, appears to be particularly
associated with anxiety or unconditioned fear (Walker and Davis, 1997; Lee and Davis,
1997; Davis, 1998). For these reasons CRFR1 antagonists are being investigated as potential
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drug therapies for anxiety disorders (Grammatopoulos and Chrousos, 2002; Reul and
Holsboer, 2002).
Syrian Hamsters and Conditioned Defeat
As stated above, territorial aggression is a common situation in which an animal will
encounter social conflict. Syrian hamsters (Mesocricetus auratus) are thought to be solitary
animals that readily defend home territories (Nowack and Paradiso, 1983). When hamsters
are singly housed in a laboratory, they will routinely attack intruders placed into their home
cages (resident-intruder model), particularly if the resident is larger than its intruder. A
dominant-subordinate (or “winner-loser”) relationship is formed quickly (Lerwill and
Makings, 1971), even though the severity of the encounters in terms of biting or wounding is
usually low. During a defeat, one hamster (usually the resident in a resident-intruder model)
will initiate an attack, which includes pursuit of the other hamster and “biting.” Biting is
usually directed to the flank of the opponent, but the skin is rarely broken during this action.
During this time the other hamster may bite back, but usually it will quickly begin to display
defensive and submissive behaviors. The dominant hamster may make additional attacks.
Finally, defeat is determined when the previously attacked hamster flees or shows
submissive/defensive behaviors without the dominant hamster making an attack. When a
Syrian hamster is defeated in an agonistic encounter, it will subsequently fail to display any
territorial aggression in future social encounters, even in its home cage in the presence of a
non-aggressive, non-threatening, smaller intruder (Potegal et al., 1993). This change in
social behavior is termed conditioned defeat.
Conditioned defeat in hamsters may be a valuable model with which to study stressresponsive behavior. It can be reliably induced by a series of four, five-minute defeats or by
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an acute 15-minute defeat (Huhman et al., 1991; Potegal et al., 1993; Jasnow and Huhman,
2001). When hamsters are defeated in this way, they subsequently show submissive
behaviors such as flight, tail lift, tooth chatter, as well as defensive postures in the presence
of a non-aggressive intruder (Potegal et al., 1993; Jasnow et al., 1999). A similar change in
behavior has been observed in defeated rats and mice (van de Poll et al., 1982; Frischknecht
et al., 1982). However, hamsters are a more desirable species to use because rats are social
animals that usually show low levels of aggressive behavior unless they are housed in
complex social situations, and aggressive strains of mice often have unacceptably high levels
of aggression and injury.
Defeated hamsters exhibit increased plasma adrenocorticotropic hormone (ACTH)
and cortisol (CORT) concentrations (Huhman et al., 1990; Huhman et al., 1991; Huhman et
al., 1992), whereas dominant hamsters do not show this response. Additionally, CRF
receptor (CRFR) antagonists reduce the expression of conditioned defeat as well as ACTH
release following conditioned defeat testing (Jasnow et al., 1999). The behavioral effect of
acute defeat in hamsters is profound, and the physiological response consistently occurs and
is unique to the defeated hamster. These effects can be obtained easily with a single
exposure to social defeat, and the response is long lasting (Huhman et al., 2003). Further, the
behavioral and physiological affects listed here occur in virtually all hamsters, eliminating
the need for prescreening. Because of the ease and consistency with which CD can be
induced, as well as the fact that CD is a more ethologically relevant model than other
artificial stressors (see above), conditioned defeat is a valuable model with which to study
stress-responsive behavior.
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Neurobiology of Conditioned Defeat
So far little is known about the circuitry controlling conditioned defeat. However, a
series of studies have shown that the amygdala and the BST are both important for CD.
Inactivation of the amygdala with the GABA agonist muscimol blocks both the acquisition
and the expression of CD (Jasnow and Huhman, 2001), and blocking NMDA receptors in the
amygdala with the antagonist AP5 blocks both acquisition and expression, as well (Jasnow et
al., 2004a). Involvement of CRF receptors has also been shown. ICV or intra-BST injection
of the non-selective CRFR antagonist D-Phe CRF(12-41) (D-Phe) or the CRFR2-specific
antagonist antisauvagine-30 (ASVG) reduces the acquisition and expression of CD (Jasnow
et al., 1999; Jasnow et al., 2004b; Cooper and Huhman, 2005a; Cooper and Huhman, 2005b).
Additionally, a combination of unilateral Ce lesion with contralateral intra-BST injection of
D-Phe CRF (thereby interrupting what would be ipsilateral “communication” between the Ce
and the BST) reduces the expression of CD. These results suggest that projections from the
Ce to the BST are involved in the expression of CD. It is already known that there are
projections from the Ce to the BST that release CRF (Sakanaka et al., 1986). Because
CRFR antagonism in the BST reduces CD, it is likely that the projections from the Ce to the
BST that are involved in CD are releasing CRF.
Scope of this Dissertation
Though there is strong evidence that the amygdala and BST are part of the
neurocircuitry mediating CD and that extrahypothalamic CRF transmission is important in
this circuitry, there is little else known about this system or what role CRF plays to modulate
CD and at which receptor subtypes. The goal of this project is to investigate the role of CRF
type 1 and 2 receptors in CD and to identify neuroanatomical locations where CRF may be
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acting. Specific Aim 1 will test the hypothesis that CRF receptors modulate the expression
of conditioned defeat by answering the following question: will a ventricular injection of
CRF enhance the acquisition or expression of conditioned defeat after a suboptimal defeat
encounter, and would this effect be due to cortisol release via HPA axis activity or central
CRF transmission? Specific Aim 2 will test the hypothesis that CRFR2, and not CRFR1, is
important in mediating the effects of CRF on conditioned defeat by answering the following
question: will CRFR1 or CRFR2 agonists given before testing enhance the expression of
conditioned defeat? Finally, Specific Aim 3 will use receptor autoradiography to test the
hypothesis that CRFR2 receptor binding is increased following defeat by answering the
following questions: 1) how are CRFR1 and CRFR2 distributed throughout stress circuits in
hamster brain, particularly in the LS, amygdala, BST, and hypothalamus, and 2) are there
differences in CRF receptor densities between defeated and non-defeated hamsters, and are
those differences reflective of changes in CRFR1 or CRFR2 receptor densities?
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Summary
Social conflict is a biologically relevant stressor that can affect physiological and
psychological markers of stress. When a Syrian hamster loses an agonistic encounter, it
shows elevated plasma adrenocorticotropic hormone (ACTH) and cortisol (CORT). A
defeated hamster also fails to display normal territorial aggression and instead displays
submissive behavior in the presence of a non-aggressive intruder, a behavioral change termed
conditioned defeat (CD). Previous studies in our laboratory have shown that blockade of
corticotropin releasing factor (CRF) receptors attenuates the expression of CD. Because
CRF is a critical component of the hypothalamo-pituitary-adrenal axis (HPA) response to
stress, it is possible that the observed increases in CORT following defeat provide feedback
important for the formation of CD. Previous studies in our laboratory have shown that
blocking ACTH release with a specific CRF type 1 receptor antagonist does not reduce the
expression of CD, however, suggesting that CRF effects are central and not peripheral. The
purpose of the present study was to further elucidate the role of CRF in CD. In Experiment
1, the glucocorticoid synthesis inhibitor metyrapone was administered SC to hamsters before
CD training or testing to determine whether CORT affects either the acquisition or
expression of CD. Metyrapone administration had no effect on CD, though it did
successfully block elevations in plasma CORT following defeat. In Experiment 2, hamsters
received a microinjection of rat/human CRF into the lateral ventricle prior to CD training or
testing to determine whether central CRF administration enhances CD acquisition or
expression after a suboptimal defeat training session. Hamsters given CRF before CD testing
exhibited significant increases in submissive behavior compared to hamsters receiving
vehicle. CRF administration also increased aggressive behavior in non-defeated hamsters.
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Collectively, these data suggest that CRF modulates CD via direct neurotropic action.
Further, it appears that CRF has different effects on agonistic behavior depending on the
hamster’s previous social experience.

Keywords: glucocorticoids, stress, conditioned defeat, metyrapone, fear conditioning,
aggression
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1. Introduction
Stressful life events are linked to an increased incidence of psychopathology,
including affective and anxiety disorders (Holsboer, 1988; Barden, 1996; Plotsky et al.,
1998; Mitchell, 1998; Arborelius et al., 1999). In order to elucidate how stress can lead to
psychological disorders, and to identify possible pharmacological therapies for those
disorders, various models of stress have been developed. Social conflict is an inevitable part
of life in many species and thus is a more biologically relevant stressor than are other
stressors commonly used in the laboratory, such as restraint or footshock. When conflict
arises, the outcome (i.e., whether the individual “wins” or “loses”) has a strong and lasting
impact. Losers of agonistic encounters, but not winners, exhibit increased heart rate,
elevated blood pressure, and suppressed immune function (Bohus et al., 1993; Blanchard et
al., 1995; Meehan et al., 1995), as well as activation of the hypothalamo-pituitary-adrenal
(HPA) axis (Pich et al., 1993; Buwalda et al., 1999; Jasnow et al., 2001). Defeated animals
also exhibit many behavioral changes, such as decreased reproductive, exploratory, or
aggressive behavior, decreased food and water intake, and increased anxiety (Heinrichs et al.,
1992; Potegal et al., 1993; Rodgers and Cole, 1993; Albonetti and Farabollini, 1994). These
physiological and behavioral effects can be used as targets for pharmacological or other
manipulations to identify specific brain regions, neurochemical signals, or molecular changes
that are important in the development of stress-induced psychological disorders.
Syrian hamsters (Mesocricetus auratus) are thought to be solitary animals that readily
defend their home territories (Nowack and Paradiso, 1983). When hamsters are singly
housed in a laboratory, they routinely attack intruders placed into their home cages (residentintruder model), particularly if the resident is larger than the intruder. A dominant-
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subordinate (or “winner-loser”) relationship is formed quickly (Lerwill and Makings, 1971),
even though the severity of the encounter between hamsters (i.e., biting or wounding) is
usually low. After a male hamster is defeated in an agonistic encounter, it will subsequently
fail to display any territorial aggression in future social encounters and will instead show
increased submissive or defensive behavior, even when these encounters occur in its own
home cage against a smaller, non-aggressive intruder (Potegal et al., 1993). This change in
social behavior is termed conditioned defeat (CD). In addition to this striking behavioral
change, defeated hamsters exhibit increased plasma adrenocorticotropic hormone (ACTH)
and cortisol (CORT) concentrations following a social encounter (Huhman et al., 1990;
Huhman et al., 1991; Huhman et al., 1992), whereas dominant hamsters do not.
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983)
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al.,
1999; Eckart et al., 2002). It has many behavioral and physiological effects, including
increased anxiety-like responding, increased arousal and HPA axis activation, and
enhancement of learning and memory in tasks such as visual discrimination, spatial learning,
inhibitory avoidance, and fear conditioning (Eckart et al., 1999; Landgraf, 2001;
Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).
CRF is a critical component of the endocrine response to stress. Following exposure to a
stressful event, CRF is released from the parvicellular portion of the paraventricular nucleus
(Pa) and it triggers release of ACTH from anterior pituitary corticotrophes. ACTH, in turn,
stimulates adrenocortical release of glucocorticoids, which has a number of effects including
gluconeogenesis to provide energy (to sustain the “flight or flight” response) and reduced
inflammation. Glucocorticoids also provide feedback to the brain to control the HPA axis
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response to stress. In addition to the critical role of CRF in the HPA axis response to stress,
CRF peptides and receptors are distributed throughout the brain (Bittencourt and Sawchenko,
2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and Hauger, 2002; Eckart et al.,
2002; Reul and Holsboer, 2002), suggesting a wider role for this peptide. Consistent with
this view, numerous studies demonstrate extrahypothalamic actions of CRF in various fear
conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et al., 1999b; Takahashi,
2001).
CRF may modulate agonistic behavior by its regulation of glucocorticoids. Acute
increases in glucocorticoids have been shown to increase aggression or submission
depending on the social context (Leshner, 1980; Leshner, 1983). Glucocorticoids might
produce these variable effects by acting on brain mechanisms to increase general arousal and
thereby increase the salience of incoming stimuli. More recently, glucocorticoids have been
proposed to directly modulate ongoing aggressive behavior through rapid effects on
neurotransmitter systems (Haller et al., 1998; Mikics et al., 2004). Glucocorticoids might
also affect future agonistic behavior by modulating memory of the social interaction.
Increased glucocorticoids produced by an acute stressful experience have been shown to
facilitate the acquisition of some associative memory tasks (Beylin and Shors, 2003).
Likewise, administration of corticosterone and glucocorticoid receptor agonists have been
shown to enhance the consolidation of memories for emotionally arousing experiences
(Buchanan and Lovallo, 2001; Roozendaal et al., 2001; Hui et al., 2004). Also, the
suppression of glucocorticoid synthesis with metyrapone impairs memory consolidation on
emotionally motivated tasks such as a water maze and inhibitory avoidance (Roozendaal et
al., 1996; Liu et al., 1999). The basolateral amygdala (BLA) is the primary brain region that
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mediates the effects of stress and glucocorticoids on memory consolidation and retrieval
(Roozendaal and McGaugh, 1997; Roozendaal et al., 2001; Roozendaal et al., 2002;
Roozendaal et al., 2004).
Previous work in our laboratory suggests that CD is modulated by CRF. D-Phe
CRF(12-41), a non-selective CRF receptor antagonist, reduces CD, whereas CP-154,526, a
selective CRF 1 receptor antagonist, blocks the plasma ACTH response to defeat but does
not reduce the display of submissive behavior (Jasnow et al., 1999). This result suggests that
CRF is acting via a central and not a peripheral mechanism. On the other hand, these data
suggest that adrenocorticoids can have a pronounced effect on behavior, including agonistic
behavior. One goal of the present study was to determine whether CRF modulates CD by
acting centrally, peripherally, or both. Based on the growing literature showing effects of
glucocorticoids on agonistic behavior, as well as learning and memory, it remains plausible
that administration of the glucocorticoid synthesis inhibitor metyrapone might reduce the
acquisition or expression of CD. In addition, we hypothesized that intracerebroventricular
injection of CRF would enhance the acquisition as well as the expression of CD following a
suboptimal defeat.
2. Materials and Methods
Subjects
Male Syrian hamsters were purchased from Charles River Laboratories.
Experimental animals were three to four months old and weighed 120-140 g at the start of the
study. The animals were individually housed for 10 days to two weeks prior to testing in a
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark
cycle. Older animals that weighed 160-180g were housed individually and used as resident
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aggressors during the defeat phase of the CD protocol. Younger animals (two months) that
weighed 100-110g were group-housed (five animals per cage) and were used as nonaggressive intruders during the testing phase. All animals were housed in polycarbonate
cages (20 x 40 x 20 cm) with corncob and cotton bedding materials and wire mesh tops.
Food and water were available ad libitum. The cages of experimental animals and resident
aggressors were not changed for at least one week prior to testing. All training or testing
occurred within the first three hours after the onset of the dark phase of the light:dark cycle in
order to minimize circadian variation of the dependent measures. All experimental animals
were handled daily for at least one week prior to the beginning of any experiment in order to
habituate them to the stress of being handled by the experimenter. During the experiment if
any animal was bitten such that it bled, the encounter was stopped and the animal was
examined and treated immediately. All procedures and protocols were approved by the
Georgia State University Institutional Animal Care and Use Committee.
Experiment 1a
To test metyrapone’s effectiveness at blocking increased CORT release following
defeat, 18 animals were injected (SC) with metyrapone (50 mg/kg or 100 mg/kg in 0.2 ml
vehicle) or vehicle 90 min prior to a 15-min training session with a resident aggressor.
Metyrapone [2-methyl-1,2-di-3pyridyl-1-propanone (Sigma)] was dissolved in polyethylene
glycol and diluted with saline to reach a final concentration of 40% polyethylene glycol.
Drug doses and delay between injection and testing were selected based on previous research
(Roozendaal et al., 1996; Liu et al., 1999). Immediately following social defeat, hamsters
were rapidly decapitated and trunk blood was collected for CORT radioimmunoassay (RIA).
Trunk blood was transferred to heparinized tubes kept on ice, centrifuged at 4ºC and 3500
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rpm for 20 min, and the plasma was stored at -20ºC until assay. Total plasma cortisol was
measured in duplicate samples at the Endocrine Core Laboratory, Yerkes Primate Research
Center of Emory University, using an RIA kit produced by Diagnostic Systems Laboratories
(Webster, TX). The normal range for this assay is 0.5 – 60 µg/dl in a 25µl dose. Intraassay
variation was 4.9%, and all samples were run together.
Experiment 1b
Experiment 1b was designed to test the effect of metyrapone on the acquisition and
expression of CD. To investigate effects on acquisition, 20 adult male Syrian hamsters were
given metyrapone (50 mg/kg) or vehicle 90 min prior to a 15-min CD training session with a
resident aggressor. To investigate effects on expression, 18 adult male hamsters were given
metyrapone (50 mg/kg) or vehicle 90 min prior to a 5-min CD test.
The conditioned defeat model has been described elsewhere (Jasnow and Huhman,
2001) and is briefly described here. Prior to each experiment, the animals were matched by
weight and randomly assigned to groups. On the training day, experimental animals were
transported to a testing room. Training consisted of one 15-min exposure to a resident
aggressor in the aggressor’s home cage. The resident aggressor reliably attacked the
experimental animal, and all of the experimental animals displayed high levels of submissive
and defensive behavior during training. To correct for the total duration of defeat, exposure
time began following the first attack by the resident aggressor (which usually occurred within
the first 30 sec of the training trial). Twenty-four hours following defeat, experimental
animals were tested for CD. The animals were transported to the testing room and a nonaggressive intruder was placed in their home cage for 5 min. Total durations of submissive,
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aggressive, social, and non-social behaviors were recorded during testing sessions (see
Behavioral Scoring and Analysis).
Experiment 2
Experiment 2 was designed to test the hypothesis that ICV injection of CRF would
enhance the acquisition and expression of CD following a suboptimal defeat training session.
A single 5-min defeat session has been shown previously to elicit very low levels of
submissive behavior in male Syrian hamsters when they are tested 24h later (Jasnow et al.,
2002). Therefore, a 5-min defeat session is considered suboptimal for inducing CD and
provides the opportunity to observe a pharmacological enhancement of CD. Hamsters were
deeply anesthetized with sodium pentobarbital (90 mg/kg) and placed in a stereotaxic
instrument. The skull was leveled between lambda and bregma prior to implantation of a
guide cannula. Hamsters were then implanted unilaterally with a 4 mm, 26-gauge guide
cannula aimed at the lateral ventricle (LV). Final stereotaxic coordinates were 0.8 mm
anterior and 1.1 mm lateral to bregma. The injection cannula (33-gauge) extended 1.1 mm
beyond the guide to reach the final depth of -3.4 mm below dura. Dummy stylets were
placed in the guide cannulae in order to keep them unobstructed. Hamsters were allowed at
least one week of recovery before commencing behavioral experiments.
To test for effects on acquisition, hamsters received injection of either vehicle or
rat/human CRF (r/hCRF; 0.2 nmol) 40 mins prior to a 5-min defeat training session as briefly
described above and elsewhere (Jasnow and Huhman, 2001). To test for effects on
expression of CD, a different group of hamsters received either vehicle or r/hCRF (0.2 nmol)
40 mins prior to testing for CD (24h following defeat training). Testing for CD occurred as
described in Experiment 1. Because r/hCRF has been reported to have anxiogenic effects

25

(Takahashi et al., 1989; Owens and Nemeroff, 1993; Weiss et al., 1994; Heinrichs et al.,
1997; Holsboer, 1999; Steckler and Holsboer, 1999; Arborelius et al., 1999; Eckart et al.,
1999; Radulovic et al., 1999a; Takahashi, 2001), a no-defeat control group was included in
Experiment 2 to control for a main effect of r/hCRF on behavior. One third of the hamsters
were exposed to a resident aggressor’s empty cage for 5 min in lieu of being defeated, and
drug was administered as described above. At the conclusion of testing, hamsters were
sacrificed and the brains collected for verification of the injection site.
CRF (rat/human CRF; Sigma) was solubilized in sterile saline (0.9%). Hamsters
received either 0.0 or 0.2 nmol r/hCRF into the LV. This dose was determined from a doseresponse curve obtained in our laboratory using either 0.0, 0.2 or 2.0 nmol r/hCRF (Faruzzi
and Huhman, 2001). Microinjections were made with a 5.0 µl Hamilton syringe connected to
the injection cannula via polyethylene tubing. A final volume of 3.0 µl was injected over the
course of 1 min, and the injection cannula was left in place for an additional 1 min to allow
for drug diffusion. Hamsters were allowed to move freely during injections.
Following testing, each hamster was given a lethal dose of sodium pentobarbital. A
volume of 0.5 µl of ink was microinjected using the same length injection needle as was used
to administer r/hCRF, and the brains were removed and stored in 10% formalin for at least
24h. A razor blade was used to slice through the LV. A hit was determined by the presence
of ink in the LV and a miss was assigned if the ink was primarily located above the lateral
ventricles or in another location. Any animal that was assigned a miss was not used in
statistical analysis.
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Behavioral Scoring and Analysis
All testing sessions were recorded and later scored by an observer blind to the
experimental conditions using Noldus Observer v. 5.0 (Noldus Information Technology,
Wageningen, Netherlands). Total duration of four classes of behavior were scored during
each 5 min test: 1) Submissive: flee, avoid, tail up, upright and side defense, full submissive
posture, stretch-attend, head flag, attempted escape from the cage; 2) Aggressive: upright and
side offense, chase, and attack (including bite); 3) Social: attend, approach, investigate, sniff,
nose touching, and flank marking; 4) Nonsocial: locomotion/exploration, self-groom,
nesting, feeding, and sleeping. A subset of sessions was scored by a second observer, and
inter-observer reliability on the total duration of submissive behavior was >90%. When drug
was administered prior to social defeat, training sessions were recorded as well and scored
for the total duration of agonistic behavior.
The total durations of submissive, aggressive, social, and non-social behavior were
individually analyzed using T-tests or one-way between-subjects analyses of variance
(ANOVAs) with drug treatment as the between-subjects factor. Tukey and Least Significant
Difference (LSD) post hoc tests were used for pairwise comparisons. Nonparametric
statistics (Mann-Whitney U tests) were used for any comparisons with a significant Levene’s
test of homogeneity of variances. Planned comparisons were used to analyze Experiment 2
data. Alpha was set at p<0.05.
3. Results
Experiment 1
Metyrapone effectively blocked the increase in cortisol generally observed after
social defeat (F(2,15)=40.5, p<0.001, Tukey tests p<0.001; Figure 1). In subsequent
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experiments, we used the lowest effective dose only (50 mg/kg). When given prior to social
defeat, however, this dose of metyrapone did not significantly alter submissive behavior
during testing (t(17)=0.03, p>0.05; Figure 2a). In addition, metyrapone given before training
did not significantly alter aggressive, social, or nonsocial behavior during testing (T-tests,
p>0.05). One animal was excluded from the study because it was not defeated by the
resident aggressor. Also, when metyrapone was given prior to testing, it did not significantly
alter the expression of submissive behavior (t(16)=0.97, p>0.05; Figure 2b) or aggressive,
social, or nonsocial behaviors (T-tests, p>0.05).
Experiment 2
Analysis using planned comparisons (defeat-CRF vs. defeat-vehicle and no-defeatCRF vs. defeat-CRF) revealed that ICV r/hCRF significantly enhanced the expression of CD
(Figure 3). Defeated hamsters that received r/hCRF prior to testing displayed significantly
more submissive behavior when tested with a non-aggressive intruder than did non-defeated
hamsters receiving r/hCRF or defeated hamsters receiving vehicle, F(1,9)=13.29 and
F(1,8)=19.79, respectively, p<0.05. Defeated hamsters that received r/hCRF also showed
significantly less nonsocial behavior during testing than did defeated hamsters that received
vehicle (F(1,8)=6.11, p<0.05). However, further analysis revealed no differences in the types
of nonsocial behaviors displayed by defeated hamsters receiving r/hCRF compared to
defeated controls. These hamsters displayed normal exploratory behavior for the majority of
the 5-min test. Finally, non-defeated hamsters receiving r/hCRF prior to testing displayed
significantly more aggressive behavior than did defeated hamsters receiving r/hCRF (MannWhitney U test, Z=-2.30, p<0.05). There was no effect of r/hCRF on the acquisition of CD
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(F(1,20)=0.06 and F(1,24)=0.16, p>0.05) or on aggressive behavior (Mann-Whitney U test,
Z=-0.84 and F(1,24)=0.14, p>0.05).
4. Discussion
Collectively, the data presented here indicate that CRF modulates the expression, but
not the acquisition of CD, and that this effect is not mediated by the HPA axis. In the current
study, administration of r/hCRF altered the expression of CD while blockade of
glucocorticoid synthesis with metyrapone did not. This finding is consistent with previous
data from our laboratory showing that blockade of CRF type 1 receptors significantly
attenuates the HPA axis response in defeated hamsters but does not affect CD (Jasnow et al.,
1999). Therefore, it would appear that CRF modulates CD through central circuitry and does
not affect CD via the peripheral hormonal stress response.
We also observed a significant increase in aggressive behavior in non-defeated
hamsters that received r/hCRF prior to testing, suggesting that CRF’s activational effects on
agonistic behavior are dependent on the previous social experience of the hamster. Thus,
defeated hamsters receiving r/hCRF show increases in submissive behavior while nondefeated hamsters exhibit increases in aggressive behavior. There are two important
implications of these data. First, CRF appears to affect agonistic behavior broadly and not
merely defensive or fearful responses as was suggested from previous studies examining CD
(Jasnow et al., 1999). Second, these data strongly suggest that there are separate neural
mechanisms controlling opposing aspects of agonistic behavior. If all dominant and
subordinate behavior was controlled by the same neural circuit, then it would be expected
that manipulations that decrease one behavior would necessarily increase the opposing
behavior. However, these and previous data (Jasnow et al., 1999; Jasnow and Huhman,
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2001; Jasnow et al., 2004a) demonstrate that, although increases in submissive behavior are
accompanied with decreases in aggressive behavior, a decrease in or the absence of
submissive behavior is not necessarily accompanied by a return of territorial aggression.
Pharmacological manipulations that decrease submission are instead associated with
increased social or nonsocial behavior, collectively suggesting that subtypes of agonistic
behavior are controlled by separate neural mechanisms. The fact that CRF may increase
either submissive or aggressive behavior suggests that it can have activational effects on
either aspect of agonistic behavior, but other factors (previous social experience, for
example) determine which behavior will be expressed. Ongoing experiments in our
laboratory are using additional control groups to investigate whether CRF is indeed
increasing multiple aspects of agonistic behavior and not just submissive behavior.
Additionally, we are examining whether these effects are specific to agonistic behavior or
result from a state of generalized anxiety or increased locomotor behavior.
In many animals, social defeat results in increased levels of plasma glucocorticoids
and decreased aggressive behavior (Brain, 1980; Sapolsky, 1990; Schuett et al., 1996). In
the present study, we showed that blocking glucocorticoid synthesis did not alter the
acquisition or expression of CD. This result is consistent with previous research from our
laboratory showing that blockade of plasma ACTH release fails to reduce CD (Jasnow et al.,
1999). Our results are also similar to those found for green anole lizards in which blocking
CORT synthesis during exposure to an aggressive video did not alter future aggressive
behavior to a novel challenger (Yang and Wilczynski, 2003). However, our results contrast
with recent evidence showing that glucocorticoids facilitate the acquisition of stress-induced
changes in behavior (Calvo et al., 1998; Liu et al., 1999; Cordero et al., 2002). Recent
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evidence also suggests that the elevation of glucocorticoids that occurs following social
defeat modulates the development of aggression in Syrian hamsters (Wommack et al., 2003).
Our study suggests that the role for glucocorticoids in regulating behavioral responses to
social defeat during puberty may not extend into adulthood. In sum, although an acute social
defeat produces activation of the HPA axis, it appears that glucocorticoid feedback is not a
critical part of the neural circuitry regulating CD.
CRF has previously been shown to modulate social learning in rats (Heinrichs, 2003).
In this earlier study, the CRF antagonist D-Phe CRF impaired social learning and r/hCRF
enhanced social learning when given prior to an initial social exposure. However, in the
present study, the fact that there is an effect on expression only and not on the acquisition of
conditioned defeat suggests that CRF may not have a role in the learning of CD. It is
possible that CRF is involved in the retrieval of social memories, though it is also possible
that CRF only has general motivational effects on agonistic behavior. Our lab does have
preliminary data suggesting that CRF antagonists block the acquisition of CD, indicating that
CRF may have a role in learning. More research is necessary to better understand the role
CRF is playing in modulating agonistic behavior and conditioned defeat in hamsters.
In conclusion, the present study demonstrates that CRF has a direct neurotrophic
effect on stress-responsive behavior in Syrian hamsters. Blockade of glucocorticoid
synthesis with metyrapone blocks neither the acquisition nor expression of submissive
behavior in previously defeated hamsters. On the other hand, blockade of CRF receptors
reduces the expression submissive behavior (Jasnow et al., 1999) and central administration
of CRF enhances the expression of submissive behavior. The current study also
demonstrates that CRF has a potent activational effect on agonistic behavior, but the type of
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behavior that is affected depends on the animal’s previous social experience. Further studies
will elucidate the role of CRF receptors in conditioned defeat by examining which receptor
subtype(s) is responsible for modulating submissive and aggressive behavior. It will also be
important to determine where in the brain CRF is acting to modulate each aspect of agonistic
behavior.
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Figure 2.1. Means ± SEM of cortisol in male hamsters receiving metyrapone (0.0, 50.0, 100
mg/kg SC). These data indicate that metyrapone significantly attenuated the cortisol
response to a 15-min social defeat stressor. (p<0.05)
Figure 2.2. Means ± SEM of duration of submissive, aggressive, social and nonsocial
behavior in male hamsters receiving metyrapone either a) before training (acquisition effects)
or b) before CD testing (expression effects). (p>0.05)
Figure 2.3. Means ± SEM of duration of submissive, aggressive, social and nonsocial
behavior in defeated and non-defeated male hamsters receiving r/hCRF either a) before
training (acquisition effects) or b) before CD testing (expression effects). (planned
comparisons: defeat-CRF vs. defeat-vehicle and no-defeat CRF vs. defeat-CRF; *p<0.05)
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ABSTRACT
The non-specific corticotropin releasing factor receptor (CRFR) agonist rat/human
CRF has previously been shown to enhance the expression of conditioned defeat (CD) in
male Syrian hamsters. In addition, it has been shown that this agonist may increase the
expression of aggressive behavior in previously undefeated hamsters, suggesting a general
role for CRF in the expression of agonistic behavior. The current study further investigated
the effects of CRF on agonistic behavior by examining which CRFR subtype is mediating
these effects. In Experiment 1a, previously defeated and non-defeated hamsters received
vehicle, ovine CRF (oCRF), a CRFR1-specific agonist, or human urocortin II (UCNII), a
CRFR2-specific agonist, prior to testing with a non-aggressive intruder. oCRF significantly
enhanced the expression of CD in defeated hamsters and showed a trend toward increased
aggressive behavior in non-defeated hamsters, while UCNII had no effect. In Experiment 1b,
previously defeated and non-defeated hamsters received vehicle or antisauvagine-30
(ASVG), a CRFR2-specific antagonist, in addition to receiving vehicle or oCRF prior to
testing. Administration of ASVG did not block the replication of previously observed effects
of oCRF on aggressive or submissive behavior, suggesting that oCRF is not working via
spillover to CRFR2. Finally, Experiment 2 was designed to test whether the effects of oCRF
observed in Experiment 1 were due to increases in anxiety-like behavior. The results showed
no effect of ICV oCRF injection on open field or defensive withdrawal behavior in compared
to vehicle hamsters. Overall, these results suggest that activation of CRFR1 has potent
enhancing effects on the expression of agonistic behavior in Syrian hamsters. Further, this
effect appears to be modulated by the hamster’s previous social experience.
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INTRODUCTION
When a male Syrian hamster (Mesocricetus auratus) is defeated in an agonistic
encounter, it will subsequently fail to display any territorial aggression in future social
encounters. The hamster will instead show increased submissive or defensive behavior, even
when these encounters occur in its own home cage against a smaller, non-aggressive intruder
(Potegal et al., 1993). This change in behavior is termed conditioned defeat (CD). In
addition to this striking behavioral change, defeated hamsters exhibit increased plasma
adrenocorticotropic hormone (ACTH) and cortisol (CORT) concentrations following a social
encounter (Huhman et al., 1990; Huhman et al., 1991; Huhman et al., 1992), whereas
dominant hamsters do not. These behavioral and physiological changes have led to an
investigation of CD as both a model of stress and of fear conditioning. These investigations
have suggested, among other things, a role for corticotropin releasing factor (CRF) in the
expression and possibly the acquisition of CD.
CRF is a 41-amino acid peptide (Vale et al., 1983) located in the anterior pituitary
and throughout the brain (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002). It
has many behavioral and physiological effects, including increased anxiety-like responding,
increased arousal and activation of the hypothalamo-pituitary-adrenal (HPA) axis. CRF is a
critical component of the HPA axis response to stress, a response which has a number of
effects including gluconeogenesis (to sustain the “flight or flight” response), reduced
inflammation, as well as negative feedback to the brain to ultimately turn off the stress
response. In addition to the critical role of CRF in the HPA axis response to stress, CRF
peptides and receptors are distributed throughout the brain (Bittencourt and Sawchenko,
2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and Hauger, 2002; Eckart et al.,
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2002; Reul and Holsboer, 2002), suggesting a wider role for this peptide. Consistent with
this view, numerous studies demonstrate extrahypothalamic actions of CRF in various fear
conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et al., 1999b; Takahashi,
2001) and in learning and memory tasks such as visual discrimination, spatial learning, and
inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg and Hauger, 2002;
Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).
Previous research in our laboratory (Jasnow et al., 1999; Jasnow et al., 2004b;
Cooper and Huhman, 2005a) has indicated that nonselective CRF receptor (CRFR)
antagonists can attenuate the expression of conditioned defeat. We have also shown that ICV
administration of the nonselective receptor agonist rat/human CRF enhances CD in
previously defeated hamsters while it enhances territorial aggression in hamsters that have
not previously been defeated (A.N. Faruzzi, M.A. Cooper, and K.L. Huhman, submitted). In
addition to the nonspecific CRF receptor antagonist D-Phe CRF (12-41), we have also shown
that administration of the CRFR2-specific antagonist antisauvagine-30 attenuates the
expression of CD (Jasnow et al., 1999; Jasnow et al., 2004b; Cooper and Huhman, 2005a),
while the CRFR1 specific antagonist CP-154,526 does not (Jasnow et al., 1999; Cooper and
Huhman, 2005a). Although these results suggest that CRFR2, and not CRFR1, is modulating
CD, investigations by other laboratories into the role of CRF in agonistic behavior have
indicated a role for CRFR1. For example, the CRFR1 receptor antagonist antalarmin reduces
defensive behavior in defeated mice (Robison et al., 2004) and reduces anxious and fearful
responses normally displayed when rhesus macaques are visually exposed to conspecifics
(Habib et al., 2000). Additionally, administration of the CRFR1 antagonist SSR125543A
reduces territorial aggression in male Syrian hamsters (Farrokhi et al., 2004). There is also
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evidence that decreased CRFR2 binding reduces maternal aggression but does not affect
intermale aggression in CRFR2-mutant mice (Gammie et al., 2005), suggesting that CRFR2
does not play an important role in offensive aggression. Thus, while data from our lab have
initially supported a more important role for the CRFR2 in the modulation of CD, other
published data indicate that the CRFR1 may also have important effects on agonistic
behavior. The purpose of the present study was to use specific CRF receptor agonists to
investigate which CRF receptor mediates the reported effects of CRF on agonistic behavior
in Syrian hamsters.
The standard training protocol for CD involves a 15-min defeat training session. A
single 5-min defeat session elicits only very low levels of submissive behavior in male Syrian
hamsters when they are tested 24h later (Jasnow et al., 2002). Because a 5-min defeat
session produces only a low level of CD, it provides the opportunity to observe a
pharmacological enhancement of CD. Using this abbreviated defeat training, we have
previously shown that ICV injection of r/hCRF enhances the expression of submissive
behavior in hamsters (A.N. Faruzzi, M.A. Cooper, and K.L. Huhman, submitted). The
current study used this design to test whether administration of ovine CRF (oCRF), a CRFR1
specific agonist (Dautzenberg and Hauger, 2002), or urocortin II (UCNII), a CRFR2 specific
agonist (Reyes et al., 2001; Jahn et al., 2004), would enhance the expression of conditioned
defeat. This study also tested whether oCRF or UCNII would enhance the expression of
aggressive behavior in hamsters that had not previously experienced social defeat. Finally,
because CRFR1 binding is associated with increases in anxiety-like behavior (Heinrichs et
al., 1997; Smith et al., 1998; Liebsch et al., 1999; Radulovic et al., 1999b; Takahashi, 2001;
Zorrilla et al., 2002; van Gaalen et al., 2002; Spina et al., 2002; Gutman et al., 2003;
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Seymour et al., 2003), which may lead to increases in defensive behavior and flight, we
examined also whether administration of oCRF increases anxiety-like behavior by testing
hamsters in open field (Wilson et al., 1976; Crawley, 1985; Lister, 1990; Chaouloff et al.,
1994) and defensive withdrawal tests (Welker, 1959; Blanchard et al., 1974; Takahashi et al.,
1989).
METHODS
Experiment 1
Subjects
Male Syrian hamsters were purchased from Charles River Laboratories.
Experimental animals were three to four months old and weighed 120-140 g at the start of the
study. These animals were individually housed for 10 days to two weeks prior to testing in a
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark
cycle. Older animals that weighed 160-180g were housed individually and used as resident
aggressors during the defeat phase of the CD protocol. Younger animals (two months) that
weighed 100-110g were group-housed (five animals per cage) and were used as nonaggressive intruders during the testing phase. All animals were housed in polycarbonate
cages (20 x 40 x 20 cm) with corncob and cotton bedding materials and wire mesh tops.
Food and water were available ad libitum. The cages of experimental animals and resident
aggressors were not changed for at least one week prior to testing to allow the animals to
scent mark their territory. All training or testing occurred within the first three hours after
the onset of the dark phase of the light:dark cycle in order to minimize circadian variation of
the dependent measures. All experimental animals were handled daily for one week prior to
training in order to habituate them to the stress of being handled by the experimenter.
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Different groups of hamsters were used for each experiment. During the experiment if any
animal was bitten such that it bled, the encounter was stopped and the animal was examined
and treated immediately. All procedures and protocols were approved by the Georgia State
University Institutional Animal Care and Use Committee.
Surgeries
Adult male Syrian hamsters were unilaterally implanted with guide cannulae aimed at
the lateral ventricle (LV). Hamsters were deeply anesthetized with sodium pentobarbital
(90 mg/kg) and were placed in a stereotaxic instrument. The skull was leveled between
lambda and bregma prior to implantation of the guide cannula. Hamsters were then
implanted unilaterally with a 4 mm, 26-gauge guide cannula aimed at the lateral ventricle.
Final stereotaxic coordinates were 0.8 mm anterior and 1.1 mm lateral to bregma. The
injection cannula (33-gauge) extended 1.1 mm beyond the guide to reach the final depth of 3.4 mm below dura. Dummy stylets were placed in the guide cannulae in order to keep them
unobstructed. Hamsters were allowed at least one week of recovery before commencing
behavioral experiments.
Experiment 1a Procedures
Experiment 1a was designed to test the hypothesis that ICV injection of ovine CRF
(oCRF), a CRFR1-specific agonist, or urocortin II (UCNII), a CRFR2-specific agonist,
enhances the expression of submissive behavior in previously defeated hamsters. Hamsters
received either vehicle, UCNII or oCRF 30 mins prior to CD testing. The conditioned defeat
model has been described elsewhere (Jasnow and Huhman, 2001) and is briefly described
here. Prior to each experiment, the animals were matched by weight and randomly assigned
to groups. On the training day, experimental animals were transported to a testing room.
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One half of the animals underwent CD training. This training typically consists of one 15min exposure to a resident aggressor in the aggressor’s home cage. In the current
experiments, however, training occurred for only 5 min in order to produce a suboptimal
defeat. During each 5-min training session, the resident aggressor reliably attacked the
experimental animal, and all of the experimental animals displayed high levels of submissive
and defensive behavior during training. To correct for the total duration of defeat, exposure
time began following the first attack by the resident aggressor (which usually occurred within
the first 30 sec of the training trial). Because we have previously observed an effect of CRF
on aggressive behavior in non-defeated hamsters (Faruzzi, Cooper, and Huhman, submitted),
a no-defeat-vehicle group was also included for comparison. In this group, the other half of
the experimental hamsters was exposed to a resident aggressor’s empty cage for 5 min in lieu
of being defeated, and drug was administered as described above. Twenty-four hours
following defeat or novel cage exposure, experimental animals were tested for CD. The
animals were transported to the testing room and a non-aggressive intruder was placed in
their home cage for 5 min. Total durations of submissive, aggressive, social, and non-social
behaviors were recorded during testing sessions (see Behavioral Scoring and Analysis). At
the conclusion of testing, all hamsters were sacrificed and the brains were collected for
verification of the injection site as described below.
Experiment 1b Procedures
Experiment 1b was designed to determine whether effects of oCRF on agonistic
behavior observed in Experiment 1a could be due to “spillover” binding at CRFR2.
Treatment occurred as described in Experiment 1a, with the exception that hamsters received
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vehicle or the CRFR2-specific antagonist ASVG in addition to oCRF. Training and testing
for CD occurred as described in Experiment 1a.
Drug Preparation and Injections
UCNII (human urocortin II; Phoenix Pharmaceuticals, Belmont CA) was solubilized
in 25% DMSO in sterile saline (0.9%). Hamsters received 0, 0.2 or 1.0 nmol UCNII (Valdez
et al., 2002). oCRF (ovine corticotropin releasing factor; Phoenix Pharmaceuticals) was
solubilized in 25% DMSO in sterile saline (0.9%). Hamsters received 0, 0.10 or 1.0 nmol
oCRF (Imaki et al., 1996; Buwalda et al., 1998; Valdez et al., 2002) into the LV. ASVG
(antisauvagine 30; Polypeptide Laboratories, Torrence CA) was solubilized in deionized
water. Hamsters received 0 or 2.74 nmol ASVG into the LV (Takahashi et al., 2001).
Microinjections were made with a 5.0 µl Hamilton syringe connected to the injection
cannula via polyethylene tubing. In Experiment 1a, oCRF/UCNII/vehicle was given 30 mins
prior to CD testing. In Experiment 1b, half the hamsters received ASVG/vehicle 10 mins
prior to receiving oCRF/vehicle; the other half of the animals received ASVG/vehicle with
oCRF/vehicle as a cocktail 30 mins prior to testing (drug solubilization was adjusted to
maintain desired concentrations for either individual injections or cocktail injections). A
final volume of 3.0 µl was injected over the course of 1 min for any individual injection, and
the injection cannula was left in place for an additional 1 min to allow for drug diffusion.
Hamsters were allowed to move freely during injections.
Following testing, each hamster was given a lethal dose of sodium pentobarbital. A
volume of 0.5 µl of ink was microinjected over 30 sec using the same length injection needle
as was used to administer agonists, and the brains were removed and stored in 10% formalin
for at least 24h. A razor blade was used to slice through the LV. A hit was determined by
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the presence of ink in the LV and a miss was assigned if the ink was primarily located above
the lateral ventricles or in another location. Any animal that was assigned a miss was not
used in the statistical analysis.
Behavioral Scoring and Analysis
All testing sessions were recorded and later scored by an observer blind to the
experimental conditions using Noldus Observer v. 5.0 (Noldus Information Technology,
Wageningen, Netherlands). During each 5 min test, the total duration (sec) of four classes of
behavior were scored and grouped as follows: 1) Submissive: flee, avoid, tail up, upright and
side defense, full submissive posture, stretch-attend, head flag, attempted escape from the
cage; 2) Aggressive: upright and side offense, chase, and attack (including bite); 3) Social:
attend, approach, investigate, sniff, nose touching, and flank marking; 4) Nonsocial:
locomotion/exploration, self-groom, nesting, feeding, and sleeping. A subset of sessions was
scored by a second observer, and inter-observer reliability on the total duration of submissive
behavior was >90%.
The total durations of submissive, aggressive, social, and non-social behavior were
individually analyzed with planned comparisons using T-tests or multivariate analysis of
variance with drug and social experience as the between-subjects factors. Least Significant
Difference (LSD) post hoc tests were used for pairwise comparisons. Nonparametric
statistics (Mann-Whitney U tests or Kruskall-Wallis tests) were used for any comparisons
with a significant Levene’s test of homogeneity of variances. Alpha was ascribed at p<0.05.
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Experiment 2
The purpose of Experiment 2 was to determine whether the effects of oCRF on
submissive or aggressive behavior are associated with increases in general anxiety-like
behavior.
Subjects
Experimental hamsters were obtained and treated as described in Experiment 1, and
surgeries were performed as described, as well. oCRF was prepared and administered at 0.0
or 1.0 nmol as described in Experiment 1.
Apparatus
The defensive withdrawal (DW) apparatus consisted of an open field with a
withdrawal chamber inside it. The open field was a 91x91x41 cm white acrylic box, open on
top, with a dark grid on the floor whose squares measured 14.5 cm2 (36 squares total). The
withdrawal chamber, which sat near one corner of the open field, was a black acrylic box
with one side open for the animal to enter and exit. The withdrawal chamber measured
32x13x20 cm in size with an inner measurement of 30.5x13x13 cm. The field and chamber
were cleaned with 100% ethanol after each animal was tested. Lighting in the field during
testing was indirect and measured approximately 800-lux white light.
Procedures
Hamsters received vehicle or oCRF injection 30 min prior to testing. To begin
testing, hamsters were placed inside the DW chamber and a door was closed to keep them
inside it until starting the observation. The experiment began with the opening of the DW
chamber, and the total duration of each test was 5 min.
Data Acquisition and Analyisis
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In contrast to other rodents under anxiogenic conditions (e.g., bright light vs. dim
light or following social defeat), Syrian hamsters display a decreased latency to enter the
open field from the DW chamber. Hamsters do exhibit rodent-typical decreases in overall
locomotor activity inside an open field under anxiogenic (i.e., bright light) conditions (A.N.
Faruzzi and K.L. Huhman, unpublished results). In the current experiment, the mean latency
to first enter the open field from the withdrawal chamber and overall locomotor activity were
compared in hamsters receiving oCRF or vehicle.
Locomotor behavior, which is a measure of anxiety as well as of sedation (Crawley,
1985; Costall et al., 1989; Lister, 1990; Menard and Treit, 1999), was recorded using
EthoVision Video Tracking, Motion Analysis & Behavior Recognition System, v. 3.0
(Noldus Information Technology b.v., Wageningen, The Netherlands). This system uses
video input and tracks the movement of the center of gravity of the animal in the arena and
stores the data on a computer where the data can be analyzed for various behaviors of
interest. Total distance traveled was used to measure overall locomotor activity. Latency (in
sec) to exit the withdrawal chamber was recorded from videotape with a stopwatch by an
observer blind to experimental conditions. Data were analyzed using T-tests, and alpha was
ascribed at p<0.05.
RESULTS
Experiment 1a
Two animals were excluded from analysis due to missed cannula placement. Of the
remaining animals, there was no effect of UCNII on behavior (F(4,48)=0.53 for submissive
behavior and F(4,48)=2.68 for aggressive behavior, p>0.05). Defeated hamsters receiving
the high dose of oCRF prior to testing displayed significantly higher levels of submissive
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behavior than did defeated hamsters receiving vehicle injections (F(2,36)=7.37, p<0.05).
Nonsocial behavior was also significantly decreased in a dose-dependent manner
(F(2,36)=14.91, p<0.05) in hamsters receiving oCRF. There were also significant increases
in submissive behavior in defeated hamsters versus non-defeated hamsters receiving vehicle
(i.e., defeated hamsters displayed CD) and in defeated hamsters receiving oCRF versus nondefeated hamsters receiving oCRF. Finally, non-defeated hamsters receiving oCRF
displayed significantly higher levels of aggressive behavior than did defeated hamsters
receiving oCRF (F(1,17)=11.90, p<0.05), and there was also a trend toward increased
aggressive behavior in non-defeated hamsters receiving oCRF compared to non-defeated
controls (F(1,10)=4.07, p=0.07). Means ± SEM for each group are displayed in Figure 1.
Experiment 1b
Defeated hamsters receiving oCRF displayed significantly higher levels of
submissive behavior than did controls (F(1,21)=6.88, p<0.05), and there was no significant
interaction of ASVG. A trend towards higher levels of aggressive behavior was observed in
all 3 drug groups (ASVG+vehicle, vehicle+oCRF, and ASVG+oCRF) compared to the
vehicle only group. Additionally, there were no differences by group in animals that
received ASVG/vehicle and oCRF/vehicle as a cocktail or as two separate injections. Means
± SEM for each group are displayed in Figure 2.
Experiment 2
There was no significant difference in time to exit the withdrawal chamber in
hamsters receiving oCRF compared to those receiving vehicle (t(22)=-0.50, p>0.05).
Additionally, there was no significant difference in total locomotor behavior (t(18)=0.30,
p>0.05).
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DISCUSSION
The current data suggest that CRF modulates the expression of submissive behavior
through its actions at CRFR1. ICV injection of oCRF significantly enhanced the expression
of CD in defeated hamsters. Further, administration of ASVG did not block this effect,
suggesting that oCRF is not working via spillover to CRFR2. The current data also show a
trend for oCRF to enhance the expression of aggressive behavior in previously undefeated
hamsters. In addition, the effects of oCRF appear not to be due to increases in general
anxiety, as there was no effect of oCRF on DW or open field behaviors. These results
suggest that activation of CRFR1 modulates agonistic behavior, in general, and that the
particular behavior that is affected is determined by the animal’s previous social experience.
It is difficult to make conclusions about the role of CRFR2 in agonistic behavior. The
fact that UCNII had no effect on aggressive or submissive behavior suggests that CRFR2
does not play a role in the modulation of CD by CRF. However, because there is no
information about binding of UCNII in hamster tissue, we cannot ignore the fact that we may
have encountered a pharmacological problem and that UCNII does not adequately bind
CRFR2 in hamsters. Given the fact that other research in our lab has shown effects of the
CRFR2-specific antagonist ASVG on reducing CD (Jasnow et al., 1999; Jasnow et al.,
2004b; Cooper and Huhman, 2005a), this possibility can not be dismissed. It is also possible
that activation of CRFR2 is necessary for CD, but that stimulation of this receptor is not
sufficient to enhance CD. Alternatively, it is possible that CRF receptors are involved in
multiple aspects of the learning and display of situation-appropriate agonistic behaviors. For
example, CRFR2 could be involved in memory formation of social defeat while CRFR1
could be involved modulating the actual display of appropriate behaviors given other factors
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(e.g., previous social experience). Either way, further investigation is needed before
conclusions can be made about the role of CRFR2 in agonistic behavior in hamsters.
Although the current results show only a trend for increased aggressive behavior in
previously undefeated hamsters, we believe the data support the possibility of an excitatory
effect of oCRF on aggressive behavior as we have demonstrated before (A.N. Faruzzi, M.A.
Cooper, and K.L. Huhman, submitted). The effect of oCRF and oCRF plus ASVG on
aggressive behavior in non-defeated hamster groups actually formed bimodal distributions.
Non-defeated hamsters receiving oCRF or oCRF plus ASVG could be divided into two
distinct populations, one that displayed zero seconds of aggressive behavior and 200+
seconds of submissive behavior, and another that displayed 150+ seconds of aggressive
behavior and zero seconds of submissive behavior. The likely explanation for the
unexpected display of submissive (and absence of aggressive) behavior in some of the “nodefeat” hamsters is that they were previously subordinate before being singly-housed for the
current study. When hamsters are shipped from the breeder, they are group-housed, and they
remain so after arriving at our institution until surgeries are performed. During these periods
of group housing, the hamsters routinely form social hierarchies. Despite these opportunities
for social experience, we have never had to prescreen hamsters for submissive/aggressive
tendencies before conducting CD experiments because virtually all hamsters defeated using
our typical training design subsequently show submissive behavior, regardless of their social
experience prior to the experiment. It is highly likely that the no-defeat groups of hamsters
that showed increased submissive behavior instead of aggressive behavior were subordinate
(i.e., had been defeated) prior to this experiment. Further support for this argument is the fact
that the levels of submissive behavior displayed by these hamsters were much higher than
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that displayed by hamsters in the 5-min defeat groups. This suggests that these hamsters
have had more substantial defeats during their period of group-housing than the 5-min
defeats that were used in the current experiment, causing them to display levels of
submissiveness similar to those seen in hamsters that have experienced longer defeats
(Jasnow et al., 2002). The addition of an experiment where hamsters are pre-screened for
submissive behavior prior to assignment to a no-defeat group would offer a definitive answer
to whether oCRF increases aggressive behavior in previously undefeated hamsters.
Overall, the current data support the hypothesis that activation of CRFR1 has potent
enhancing effects on the expression of agonistic behavior in Syrian hamsters. Further, this
effect is modulated through an unknown mechanism by the hamster’s previous social
experience (i.e., having been defeated or not), resulting in enhancement of either submissive
behavior in previously subordinate hamsters or aggressive behavior in previously dominant
hamsters, respectively.
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FIGURE CAPTIONS
Figure 3.1. Means ± SEM of duration of submissive, aggressive, social and nonsocial
behavior in defeated and non-defeated male hamsters receiving oCRF or vehicle before CD
testing. (planned comparisons were used to analyze this data- spurious comparisons are not
illustrated; *p<0.05)
Figure 3.2. Means ± SEM of duration of submissive and aggressive behavior in a) nondefeated and b) defeated male hamsters receiving ASVG/vehicle and oCRF/vehicle before
CD testing. (planned comparisons were used to analyze this data- spurious comparisons are
not illustrated; *p<0.05)
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ABSTRACT
Corticotropin releasing factor (CRF) is located throughout the brain and has many
behavioral and physiological effects. Binding of agonists to CRF receptors can cause HPA
axis activation, changes in levels of anxiety or depression, decreases in feeding as well as
changes in blood pressure. We have previously shown that binding of CRF to its receptors
can have profound effects on agonistic behavior in Syrian hamsters. CRF receptor
distribution has been studied in a number of species, but the results have been inconsistent.
No reports exist of CRF receptor distribution in hamster brain. Therefore, the goal of this
study was to provide an autoradiographical description of CRFR1&2 distributions throughout
hamster brain. The current data reveal a number of similarities and differences with previous
reports of CRFR distributions in other species. Additionally, these data provide specific
information about CRFR1 and CRFR2 binding in functional subdivisions of the extended
amygdala, which is of particular interest to those examining anxiety, fear responding and
social conflict.

KEYWORDS: autoradiography, mapping, extended amygdala, bed nucleus of the stria
terminalis, hypothalamus
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INTRODUCTION
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983)
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al.,
1999; Eckart et al., 2002). CRF has many behavioral and physiological effects, including
increased anxiety-like responding, increased arousal and HPA axis activation, enhanced fear
conditioning, and enhanced learning and memory in tasks such as visual discrimination,
spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg
and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002). CRF is a
critical component of the HPA axis response to stress, which ultimately has a number of
effects including gluconeogenesis (to sustain the “flight or flight” response) and reduced
inflammation, as well as feedback to the brain to control these peripheral responses. In
addition to its effects via HPA axis activation, CRF peptides and receptors are distributed
throughout the brain (Bittencourt and Sawchenko, 2000; Lewis et al., 2001; Reyes et al.,
2001; Dautzenberg and Hauger, 2002; Eckart et al., 2002; Reul and Holsboer, 2002),
suggesting a more direct role in behavior.
There are currently two known receptor subtypes in the CRF family (CRFR1 and
CRFR2). Both subtypes are Gs protein-coupled and primarily activate adenylyl cyclase to
increase cyclic AMP levels, though they are also associated with other signaling pathways
(Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).
Binding of agonists to CRFR1 causes HPA axis activation, increased anxiety, increased
depression, decreased feeding, and decreased inflammatory response, Binding of agonists to
CRFR2 causes decreased feeding, decreased gastric emptying, decreased depression (except
when administered into the LS), increased vasodilation, and decreased blood pressure
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(Holsboer, 1999; Steckler and Holsboer, 1999; Arborelius et al., 1999; Eckart et al., 1999;
Koob and Heinrichs, 1999; Takahashi, 2001; Dautzenberg and Hauger, 2002; Eckart et al.,
2002; Grammatopoulos and Chrousos, 2002). The role that CRFR2 plays in anxiety-like
behavior is not well understood, as both anxiogenic and anxiolytic actions have been reported
(Eckart et al., 1999; Hashimoto et al., 2001; Takahashi et al., 2001; Dautzenberg and
Hauger, 2002; Pelleymounter et al., 2002; Reul and Holsboer, 2002).
There are studies mapping CRF receptor distribution in rat or rhesus monkey brain.
In general, CRFR1 is found throughout the brain in areas important for sensory information
processing and motor control, while CRFR2 is more restricted to subcortical regions (Reul
and Holsboer, 2002). CRFR1 mRNA expression has been found in sites including the
anterior pituitary, cerebral cortex, cerebellum, amygdala, hippocampal formation,
hypothalamus, areas of the brain stem, septum, BST, and olfactory bulb. CRFR2 mRNA
expression has been found in areas including the hippocampal formation, amygdala, LS, BST
and areas of the hypothalamus and brainstem (Eckart et al., 1999; Bittencourt and
Sawchenko, 2000; Dautzenberg and Hauger, 2002).
Although there are numerous studies mapping CRF receptors, there is a high degree
of variability in reported receptor distributions. For example, some studies report minimal
CRFR1 binding or CRFR1 mRNA expression in the Ce (Radulovic et al., 1999a) while
others report high densities (Rybnikova et al., 2003). There are also differences in reported
distributions in the BST. Rominger, et al., (Rominger et al., 1998) report high levels of
CRFR2 binding in the BST while others report only moderate levels (Chalmers et al., 1995;
Radulovic et al., 1999a). There are many differences other than these (for more examples
see: (Chalmers et al., 1995; Rominger et al., 1998; Radulovic et al., 1999a; Bittencourt and
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Sawchenko, 2000; Rybnikova et al., 2003). Many of these differences may be explained by
differences in methodology. Specifically, most of these studies have examined mRNA
expression while only a few have directly examined receptor densities instead of, or in
addition to, mRNA expression. In one study, CRF receptor distribution in primates was
examined using both autoradiography and in situ hybridization (ISH), and some dramatic
disagreements between receptor binding and mRNA expression were found (Sanchez et al.,
1999). While this comparison provides some useful information about CRF receptors (i.e.,
receptors are likely transported to these areas from elsewhere; (Sanchez et al., 1999) it
highlights the problem that ensues from relying solely on mRNA expression to determine
distribution of peptide binding sites.
Another possible explanation for differences among reports of CRF receptor
distribution is that the neuroanatomy used for localization of receptors or mRNA is
inconsistent and imprecise. There are no definitive boundaries between brain areas, and
there are also numerous differences in the terminology used to delineate brain nuclei. For
example, an analysis of three studies mapping CRF receptors in rat brain revealed little
agreement in the neuroanatomical localization of receptors in the BST. Of the two that
mapped expression in the BST, one examined only the medial division (Chalmers et al.,
1995), while the other examined distribution throughout the BST as divided into
anteromedial, anterolateral, oval nucleus, and the posterior parts (Bittencourt and
Sawchenko, 2000). In contrast, experiments investigating the role of the BST in conditioned
and unconditioned fear have focused primarily on the dorsal and ventral parts of the medial
and lateral divisions (Walker and Davis, 1997). Therefore, currently available data on the
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distribution of CRF receptors in the BST do not provide adequate information about the
localization of CRF receptors in subdivisions important for fear and anxiety-like responses.
Our laboratory studies the role of CRF receptors in agonistic behavior in Syrian
hamsters (Mesocricetus auratus). We have shown that ICV and intra-BST injections of
CRFR antagonists attenuate forms of agonistic behavior and that ICV injection of CRFR
agonists enhance agonistic behavior, but we do not know where CRF acts to have these
effects. We are particularly interested in CRFR distributions in the extended amygdala as
well as in other areas important for emotionality, arousal, and agonistic behavior, such as the
hypothalamus, PAG, and the DR. The current study provides an autoradiographical
description of CRFR1&2 distributions throughout the hamster brain.
METHODS
Subjects
Male Syrian hamsters were purchased from Charles River Laboratories.
Experimental animals were three to four months old and weighed 120-140 g at the start of the
study. The animals were individually housed for one week prior to sacrifice in a temperature
controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark cycle. All
animals were housed in polycarbonate cages (20 x 40 x 20 cm) with corncob and cotton
bedding materials and wire mesh tops. Food and water were available ad libitum, and cages
were not changed while they were individually housed. Animals were handled daily during
the week prior to sacrifice in order to habituate them to the stress of being handled by the
experimenter. Tissue from four hamsters was ultimately used for autoradiography. All
procedures and protocols were approved by the Georgia State University Institutional Animal
Care and Use Committee.
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CRF Receptor Autoradiography
Autoradiography procedures were performed similarly to those described previously
(Sanchez et al., 1999; Lim et al., 2005) and are described briefly here. Receptor
autoradiography was performed with [125I-Tyr0]-sauvagine, which has high affinity for both
CRFR1 (Kd=0.2-0.4 nM) and CRFR2 (Kd=0.1-0.3 nM) (Grigoriadis et al., 1996; Primus et
al., 1997). To identify CRFR2 binding sites, [125I-Tyr0]-sauvagine was combined with an
excess of unlabeled CP-154,526, a CRFR1-selective antagonist (Schulz et al., 1996). To
identify CRFR1 binding sites, optical density readings of total CRFR binding minus specific
CRFR2 were used. The subtraction technique is further described below in Data Analysis.
Animals were rapidly decapitated, and their brains were removed and flash-frozen on
dry ice before being stored in -80ºC. Brains were sliced on a cryostat at 20 µm, and sections
were thaw-mounted onto Superfrost Plus slides (Fisher, Pittsburgh, PA) and stored at -80ºC
until assayed. Five sets of continuous sections were collected from prefrontal cortex through
hindbrain. Three adjacent sets of sections were processed for CRFR total binding, CRFR2
binding, and CRFR nonspecific binding, similar to previously described protocols (Sanchez
et al., 1999; Lim et al., 2005).
Slides were thawed at room temperature until dry and fixed for 2 min in 0.1%
paraformaldehyde-PBS solution (pH 7.4). Slides were then rinsed twice in 50 mM Tris base
(pH 7.4) solution for 10 min each, then incubated in tracer for 60 min. Tracer buffer
consisted of a 50 mM Tris base, 10 mM MgCl, 0.1% bovine serum albumin, 0.05%
bacitracin, plus 0.2 nM [125I-Tyr0]-sauvagine (PerkinElmer/NEN, Boston, MA), which binds
both CRFR1 and CRFR2. Slides were then rinsed with 50 mM Tris base plus 10 mM MgCl
(pH 7.4) for 3x5 min, plus 30 min with stirring on a stir plate with a magnetic bar. Slides
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were then dipped in deionized H2O, blown dry with cool air, and apposed to Kodak MR film
for 72 hr with [125I] microscale standards (PerkinElmer/NEN). Representative brain sections
are shown in Figure 1.
CRFR2 Autoradiography
An adjacent set of slides were processed at the same time for CRFR2 receptor sites.
CRFR2 binding was measured as described above, with the addition of unlabeled CP154,526-1 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]-pyrimidin-4yl]-ethylamine), a selective CRFR1 antagonist, which was kindly provided by Michael J.
Owens, Ph.D. The concentration of CP-154,526 used in this study was 1 µM, which
competes with [125I-Tyr0]-sauvagine for CRFR1, but not CRFR2, binding sites because the Ki
for inhibition of binding by [125I-Tyr0]-sauvagine to CRFR2 is greater than 10 µM (Schulz et
al., 1996). This protocol has been successfully used to assay rat, monkey, and vole tissue
(Sanchez et al., 1999; Skelton et al., 2000; Lim et al., 2005). Representative brain sections
are shown in Figure 1.
CRFR Nonspecific Binding
A third set of adjacent slides were processed for nonspecific binding for both CRFR1
and CRFR2 as described above in CRF Receptor Autoradiography, with the addition of 1
µM cold sauvagine (American Peptide, Sunnyvale, CA) to the tracer buffer containing the
[125I-Tyr0]-sauvagine to compete with CRFR1 and CRFR2 binding sites as described
previously (Sanchez et al., 1999; Lim et al., 2004).
Data Analysis
The fourth and fifth sets of adjacent slides were stained for thionin and
acetylcholinesterase (AChE), respectively, to better delineate brain regions (specifically
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AChE for amygdalar subnuclei) for image analysis (see Figures 2 and 3). Total CRFR
binding, CRFR2 binding and nonspecific binding were quantified using MCID Basic v. 7.0
(Imaging Research Inc., Ontario, Canada). AChE- and thionin-stained sections were used to
delineate the borders of brain regions of interest before sampling. Bilateral measurements
were averaged for each brain region across two or three sections. Optical density readings
were measured in decompositions per minute per milligram tissue (dpm/mg) based on a
known set of [125I] microscales exposed on each film.
Specific CRFR2 binding values were obtained by subtracting background values from
each section and then nonspecific binding values from [125I-Tyr0]-sauvagine binding in the
presence of 1 µM CP-154,526. Specific CRFR1 binding values were calculated by
subtracting background values from each section and nonspecific binding, and then
subtracting corrected CRFR2 binding.
Statistics
The following equations were used to obtain the corrected values for each CRFR1
and CRFR2: (R2-background-NScor)=R2 corrected value; (R1R2-background-NScorR2corrected value)=R1 corrected value (NScor=NS-NSbackground). The corrected values
for each region were averaged for each animal, and an overall mean and standard deviation
was calculated across animals for each brain region.
Final values for each brain region were assigned quantitative values according to
respective percentile distributions of averaged, corrected values for all regions measured.
Optical density was expressed as: ++++, very dense binding (≥65%); +++, dense binding
(<65%, ≥45%); ++, moderate binding (<45%, ≥25%); +, light binding (<25%, ≥5%); and +/-,
sparse or no binding (<5%).
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Photomicrograph Production Details
Digital images were obtained from film autoradiograms using MCID Basic v. 7.0
(Imaging Research Inc., Ontario, Canada). Digital images of AChE- or thionin-stained
sections were taken using a Hewlett-Packard Scanner. Images were then imported into
Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA), cropped, and minimally adjusted for
brightness and contrast in order to clarify the scientific point of interest. Adobe Photoshop
7.0 was also used to add all image text and arrows.
RESULTS
Figure 1 shows CRFR distribution throughout the hamster brain. Panes labeled with
“a” display CRFR1&2 distribution, and panes labeled with “b” show the corresponding
CRFR2 distribution. Thionin or AChE stained sections are also displayed to aid in
localization. Table 2 lists the distribution of CRFR1 and CRFR2 throughout a number of
brain sites. This list highlights many areas related to emotionality and to social and agonistic
behavior, which are of particular interest to our laboratory, and is not meant to be exhaustive.
The following describes distributions of CRFR1 and CRFR2 in these areas.
Distribution of CRFR1
CRFR1 were distributed widely throughout the cortex (see Figure 1). Some
particular prefrontal cortical areas included the Cg (Mean ± SEM dpm/mg;
Cg1=718.39±11.03, Cg2=934.83±12.48), the IL (831.01, n=1), and the PrL (1442.84, n=1).
CRFR1 were also spread throughout the CPu (340.57±7.85) with a higher density in the
ventral striatum (610.49±9.54). The LS and the BST had light CRFR1 binding
(LS=195.30±7.64; BSTA=200.24±6.54, BSTPM=147.70±7.08, BSTPI=244.68±8.38,
BSTPL=273.65±10.40). The AStr had moderate CRFR1 binding (843.94±14.84).
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CRFR1 binding was spread throughout the amygdala, with the exception of the Ce,
which had sparse binding (112.91±6.75). The La (anterior) and MeA had moderate binding
(668.35±11.65 and 823.09±12.31, respectively), while the La (posterior), BLA (anterior and
posterior), I, and MeP showed moderate to light binding (464.97±9.69, 344.37±8.22 and
293.82±8.95, 283.06±8.33, and 276.17±7.97, respectively). However, there was dense
binding in the BMA (1228.80±14.92), BLV (1388.75±20.75), BMP (1455.25±16.62), and
PMCo (1692.72±12.77), and very dense binding in the PLCo (1824.26±17.67).
There was sparse binding in all measured areas of the hippocampus
(CA1=46.51±3.37, CA2-3=28.60±3.38, DG=73.74±4.10) except for the S, which had light
binding (292.50±5.59). The hypothalamus also showed moderate to light binding in areas
including the AH (230.74±5.65), LH (177.53±3.76), Pa (138.34±66.23), SCN (158.48±5.87)
and VMHL (173.94±5.53), and sparse binding in the VMHM (106.21±4.84) and Arc
(81.58±4.14).
The SuG had very dense CRFR1 binding (2660.16±23.39). There was light binding
in the PAG (209.47±7.60) and DR (234.33±10.51), and there was sparse binding in the MnR
(130.10±6.18) and PMnR (66.99±4.64). The CG and NTS also had sparse binding
(98.44±5.72 and 41.13±3.73, respectively). One area that had moderate CRFR1 binding
(639.98±16.15) is as of yet unidentified, though when compared to the hamster atlas (Morin
and Wood, 2001) it appears to overlap with areas labeled as pre-, para-, and postsubiculum
(illustrated with arrow in pane 33a of Figure 1).
Distribution of CRFR2
CRFR2 were densely distributed throughout choroid plexus and therefore showed
high binding in areas like the lateral ventricles (see arrow in panes 8a and 8b of Figure 1).
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CRFR2 was sparsely distributed throughout the cortex or striatum (e.g., Cg1=76.73±4.27,
Cg2=113.84±4.91, IL=115.85 (n=1), PrL=103.89 (n=1), CPu=89.26±5.20, and ventral
striatum=99.84±5.38). There was dense binding (1959.10±20.95) in the LS. There was
sparse to no binding in the BST (BSTA=137.29±5.94, BSTPI=68.62±4.49,
BSTPM=2.75±1.17) except in the BSTPL, which had light binding (197.37±7.63), though
binding was stronger in very discreet areas of the BSTPL (see arrow in panes 7a and 7b of
Figure 1). The AStr showed moderate CRFR2 binding (971.72±10.08).
There was CRFR2 binding throughout the amygdala, with the exception of the MeA
and MeP, which showed sparse binding (157.75±5.29 and 91.95±5.34, respectively). There
was light to moderate binding in the Ce (276.95±2.45), BMA (302.92±5.05), La (posterior;
484.34±6.74), BLA (posterior; 514.74±5.71), BMP (526.66±8.82), BLA (anterior;
597.54±4.65) and BLV (642.62±9.48). The La (anterior) and PMCo had moderate binding
(1617.92±8.61 and 1367.38±9.68, respectively), and the intercalated nucleus had dense
binding (2403.82±9.95). Finally, there was very dense CRFR2 binding in the PLCo
(3953.02±21.26).
As with CRFR1, there was sparse to no CRFR2 binding in the hippocampus
(CA1=29.39±2.75, CA2-3=26.99±2.33, DG=31.36± 2.56, S=5.48±2.61). Much of the
hypothalamus showed sparse binding in areas including the Arc (41.52±3.18), Pa
(46.40±2.88), AH (149.93±5.66), and SCN (154.68±4.69). There were slightly higher levels
of binding in the VMHM (206.55±4.27), VMHL (222.09±5.07), and LH (290.07±6.03).
There was sparse CRFR2 binding in the SuG (108.11±5.26). The PAG showed light
binding (307.39±9.79), as did the DR (579.91±8.57), PMnR (219.09±2.55), and the NTS
(which was approaching moderate; 696.99±6.75). There was sparse binding in the MnR
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(155.26±2.80) in the CG (29.23±2.14). Finally, the unidentified area described above as
overlapping with the areas labeled as pre-, para-, and postsubiculum on the hamster atlas
(Morin and Wood, 2001) showed very dense CRFR2 binding (4308.08±22.26; illustrated
with arrow in pane 33b of Figure 1).
DISCUSSION
The current study is the first to illustrate the distribution of CRF receptors throughout
hamster brain. The current data reveal a number of similarities and differences with previous
reports of CRFR distributions in other species. Additionally, it provides specific information
about CRFR1 and CRFR2 binding in functional subdivisions of the extended amygdala,
which is of particular interest to those examining anxiety, fear responding and social conflict.
Although comparing our results with existing reports of CRFR distribution is difficult
due to the lack of consistent techniques (as described in detail in the Introduction), it is
possible to make some interesting comparisons. For example, the density of CRFR1 and
CRFR2 in the LS in the current study is consistent with reports of CRFR1 and CRFR2
mRNA expression in other studies (low CRFR1 and high CRFR2; Chalmers et al., 1995;
Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003).
Receptor distribution was also consistent with most reports of little to no mRNA expression
in the Ce (Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000), with the exception of
one study reporting high CRFR2 mRNA expression (Rybnikova et al., 2003). On the other
hand, moderate to high CRFR2 mRNA expression has been reported in the MeA (Chalmers
et al., 1995; Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al.,
2003), though the present study found very minimal CRFR2 binding. Additionally, despite
the differences among reports as to the division of the hippocampus, there is still a very
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obvious difference in hippocampal binding in the current study overall compared to other
studies. While others reported varying mRNA expression (Chalmers et al., 1995; Radulovic
et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003), the current study
demonstrates only sparse binding throughout most of the hamster hippocampus. Because the
four other studies compared mRNA expression only, it is possible that those receptors are
transported elsewhere or that post-transcriptional changes (resulting from stress, for example)
are necessary for higher densities of functional CRF receptors in hamsters.
There are also some specific differences between the current and existing studies in
CRFR1 and CRFR2 distribution in the hypothalamus. The current results are consistent with
a previous report of little to no CRFR1 or CRFR2 mRNA expression in the Arc (Rybnikova
et al., 2003) but disagree with another study reporting moderate mRNA expression
(Bittencourt and Sawchenko, 2000). Similarly, while other studies report CRFR2 mRNA
expression to be high in the VMH (Chalmers et al., 1995; Radulovic et al., 1999a;
Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003) and moderate in the Pa (Chalmers
et al., 1995; Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000), the current study
reveals moderate and low CRFR2 binding in these areas, respectively.
CRF receptors have been shown to have a role in HPA axis activation, anxiety,
feeding, learning and memory, conditioned defeat, and conditioned and unconditioned fear
responses (Liang et al., 1992; Lee and Davis, 1997; Birnbaum and Davis, 1998; Jasnow et
al., 1999; Eckart et al., 1999; Landgraf, 2001; Faruzzi and Huhman, 2001; Dautzenberg and
Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002; Toufexis et al.,
2004; Cooper and Huhman, 2005a; Cooper and Huhman, 2005b). Consistent with these
findings, CRFR1 and/or CRFR2 were found in Syrian hamster brain in many regions
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involved in these behaviors, such as prefrontal cortex, subdivisions of the BST and
amygdala, the DR, and the LS. It has also been suggested that CRFR2 may act specifically
to oppose or modulate responses mediated by CRFR1 (Reyes et al., 2001; Grammatopoulos
and Chrousos, 2002). The current data may provide support for this hypothesis because they
reveal overlap of CRFR1 and CRFR2 in several subcortical areas.
Of particular interest, given our data on conditioned defeat, was the distribution of
CRFR1 and CRFR2 in the extended amygdala. We have previously shown that non-specific
and CRFR2-specific antagonists attenuate the acquisition and expression of conditioned
defeat in hamsters when given into the BST (Cooper and Huhman, 2005a) but not into the Ce
(Jasnow et al., 2004b). It was therefore important to characterize CRFR2 distribution within
subregions of the BST in order to suggest specific sites of action and to validate proposed
pathways (like that described in (Jasnow et al., 2004b). The current results indicate the
existence of discreet densities of CRFR2 in the BSTPL that may be mediating effects of CRF
antagonists on conditioned defeat. Consistent with this idea, Cooper and Huhman (Cooper
and Huhman, 2005a) have demonstrated reductions in submissive behavior following
injection of CRFR antagonist specifically targeted at the BSTPL. Also, because ongoing
studies in our laboratory have suggested a role for the DR in the acquisition and expression
of conditioned defeat (M.A. Cooper, personal communication) as well, it was of interest to
characterize the distribution of CRF receptors in this region. In the current study, both
CRFR1 and CRFR2 binding were observed in the DR, with a higher density of CRFR2.
Finally, we have previously shown that ICV injection of a specific CRFR1 agonist increases
the expression of agonistic behaviors in hamsters, suggesting a role for CRFR1 in areas
important for modulating aggressive and defensive behaviors (Faruzzi, Zelinski, Tenenbaum,
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and Huhman, submitted). The fact that CRFR1 binding was observed in areas such as the
PAG, AH, LH, CG, and other regions related to aggression and defense systems will help
pinpoint particular sites for further investigation of these effects.
Overall, CRFR1 is found throughout hamster brain while CRFR2 appears to be more
confined to subcortical areas. While this finding is in agreement with most studies reporting
CRF receptor distributions, there are many region-specific differences in distribution
between hamster and rat and possibly differences between mRNA expression and receptor
binding. The mapping presented in the current study provides a specific resource for the
investigation of the role of CRF receptors in Syrian hamster behavior as well as contributes
to findings obtained from investigation of other species.
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Figure 4.1. CRFR total binding (labeled with “a”) and CRFR2 binding (labeled with “b”)
throughout hamster brain from prefrontal cortex to cerebellum (numbered 1-38). Pane
numbers correspond to numbers on adjacent thionin-stained slides in Figure 4.2 and AChEstained slides in Figure 4.3.
Figure 4.2. Adjacent thionin-stained slides to autoradiography slides. Numbers correspond
to numbers in Figures 4.1 and 4.3.
Figure 4.3. Adjacent AChE-stained slides of the extent of the amygdala. Numbers
correspond to numbers in Figures 4.1 and 4.2.
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27a

27b

21a

21b

28a

28b
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29a

29b

34a

34b

30a

30b

35a

35b

31a

31b

36a

36b

32a

32b

37a

37b

33a

33b

38a

38b
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1

8

15

22

2

9

16

23

3

10

17

24

4

11

18

25

5

12

19

26

6

13

20

27

7

14

21

28

77

29

32

35

30

33

36

31

34

37

38

78

11

14

17

20

12

15

18

21

13

16

19

22
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Table 4.1. Abbreviations
Region

Abbreviation

Cortex
cingulate cortex 1
cingulate cortex 2
prelimbic cortex
infralimbic cortex

Cg1
Cg2
PrL
IL

Striatum
caudate putamen

Lateral Septum
Bed Nucleus of the Stria Terminalis
anterior
posteromedial
posterointermediate
posterolateral

Amygdalostriatal Transition Area
Amygdala
anterior lateral
anterior medial
intercalated
anterior basolateral
central
anterior basomedial
posterior lateral
posterior medial
ventral basolateral
posterior basomedial
posterior basolateral
posterior lateral cortical
posterior medial cortical

CPu
LS
BSTA
BSTPM
BSTPI
BSTPL
AStr
La
MeA
I
BLA
Ce
BMA
La
MeP
BLV
BMP
BLA
PLCo
PMCo

Hippocampus
dentate gyrus
subiculum

DG
S

Hypothalamus
anterior
lateral
paraventricular
suprachiasmatic
lateral ventromedial
medial ventromedial
arcuate
Superior Colliculus, superficial gray layer

Periaqueductal Gray
Raphe
median raphe
paramedian raphe
dorsal raphe

Central Gray
Nucleus of the Solitary Tract

AH
LH
Pa
SCN
VMHL
VMHM
Arc
SuG
PAG
MnR
PMnR
DR
CG
Sol

Abbreviations match those used in A stereotaxic atlas of the golden
hamster brain (Morin and Wood, 2001).
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Table 4.2. 125I-sauvagine binding to CRFR1 and
CRFR2 in Syrian hamster brain
CRFR1 CRFR2
Region
Cortex
cingulate cortex 1
cingulate cortex 2
prelimbic cortex
infralimbic cortex

++
++
+++
++

+/+/+/+/-

+
+
+

+/+/+++

+
+
+
+
++

+/+/+/+
+

++
++
+
+
+/+++
+
+
+++
+++
+
++++
+++

++
+/+++
+
+
+
+
+/+
+
+
++++
++

+/+/+/+

+/+/+/+/-

+
+
+
+
+
+/+/++++

+/+
+/+/+
+
+/+/-

+

+

+/+/+
+/-

+/+
+
+/-

Unidentified*

++

++++

Nucleus of the Solitary Tract

+/-

+

Striatum
caudate putamen
ventral striatum

Lateral Septum
Bed Nucleus of the Stria Terminalis
anterior
posteromedial
posterointermediate
posterolateral

Amygdalostriatal Transition Area
Amygdala
anterior lateral
anterior medial
intercalated
anterior basolateral
central
anterior basomedial
posterior lateral
posterior medial
ventral basolateral
posterior basomedial
posterior basolateral
posterior lateral cortical
posterior medial cortical

Hippocampus
CA1
CA2-3
dentate gyrus
subiculum

Hypothalamus
anterior
lateral
paraventricular
suprachiasmatic
lateral ventromedial
medial ventromedial
arcuate

Superior Colliculus, superficial gray layer
Periaqueductal Gray
Raphe
median raphe
paramedian raphe
dorsal raphe

Central Gray

CRFR1 and CRFR2 distribution throughout various brain sites as
determined from optical density measurements. Values are presented
according to percentile distributions: ++++ very dense binding
(≥65%), +++ dense binding (<65%, ≥45%), ++ moderate binding
(<45%, ≥25%), + light binding (<25%, ≥5%), +/- sparse or no binding
(<5%).
*Appears to overlap with areas labeled as pre- and post-subiculum on
a Syrian hamster atlas (Morin and Wood, 2001), but positive
identification of this site is yet unknown.
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ABSTRACT
When a male Syrian hamster is defeated in an agonistic encounter, it will
subsequently fail to display territorial aggression and will, instead, display submissive
behavior in the presence of a non-aggressive intruder, a response known as conditioned
defeat (CD). Previous research in our laboratory has suggested roles for corticotropin
releasing factor (CRF) receptor subtypes in the acquisition and expression of CD. The
current study investigated whether CRF receptor binding in brain sites important for fear
conditioning, expression of unconditioned fear, and defensive behavior. Tissue was collected
at two time-points following defeat (24 and 72 hr), and autoradiography was performed for
CRF type 1 and type 2 receptor binding. Analysis revealed no significant differences
between winners, defeated hamsters, or controls at either time point in any brain area
investigated. While it is acknowledged that an exhaustive examination of autoradiography
results may reveal a yet-undiscovered effect, it is likely that alterations following social
interaction reflect a change in peptide availability than receptor binding. Finally, directions
for further investigation are discussed.
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INTRODUCTION
When a male Syrian hamster (Mesocricetus auratus) is defeated in an agonistic
encounter, it will subsequently fail to display any territorial aggression in future social
encounters. A defeated hamster will instead subsequently show increased submissive
behavior, even when these encounters occur in its own home cage against a smaller, nonaggressive intruder (Potegal et al., 1993). This change in behavior is termed conditioned
defeat (CD). In addition to this striking behavioral change, defeated hamsters exhibit
increased plasma adrenocorticotropic hormone (ACTH) and cortisol (CORT) concentrations
following a social encounter (Huhman et al., 1990; Huhman et al., 1991; Huhman et al.,
1992), whereas dominant hamsters do not. These behavioral and physiological changes have
led to investigation of CD as both a model of stress and of fear conditioning. These
investigations have suggested, among other things, a role for corticotropin releasing factor in
the expression and possibly the acquisition of CD.
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983)
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al.,
1999; Eckart et al., 2002). It has many behavioral and physiological effects, including
increased anxiety-like responding, increased arousal and hypothalamo-pituitary-adrenal
(HPA) axis activation (Jezova et al., 1999). CRF is a critical component of the HPA axis
response to stress, which has a number of effects including gluconeogenesis (to sustain the
“flight or flight” response), reduced inflammation, as well as negative feedback to the brain
to control these peripheral responses. In addition to the critical role of CRF in the HPA axis
response to stress, CRF peptides and receptors are distributed throughout the brain
(Bittencourt and Sawchenko, 2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and
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Hauger, 2002; Eckart et al., 2002; Reul and Holsboer, 2002), suggesting a wider role for this
peptide. Consistent with this view, numerous studies have demonstrated extrahypothalamic
actions of CRF in various fear conditioning paradigms (Steckler and Holsboer, 1999;
Radulovic et al., 1999b; Takahashi, 2001) and in learning and memory tasks such as visual
discrimination, spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf,
2001; Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos,
2002).
Previous research in our laboratory (Jasnow et al., 1999; Jasnow et al., 2004b;
Cooper and Huhman, 2005a) has indicated that nonselective CRF receptor (CRFR)
antagonists can attenuate the expression of conditioned defeat. We have also shown that ICV
administration the nonselective receptor agonist rat/human CRF enhances CD and possibly
territorial aggression in hamsters that have not previously been defeated (A.N. Faruzzi, M.A.
Cooper, and K.L. Huhman, submitted). In addition, we have reported that administration of
the nonspecific CRF receptor antagonist D-Phe CRF (12-41) or the CRFR2-specific
antagonist antisauvagine-30 attenuates the expression of CD (Jasnow et al., 1999; Jasnow et
al., 2004b; Cooper and Huhman, 2005a), while the CRFR1 specific antagonist CP-154,526
does not (Jasnow et al., 1999; Cooper and Huhman, 2005a).
After an acute defeat, the behavioral change observed in hamsters is noticeable 24
hours later and is long-lasting (Huhman et al., 2003). It would therefore be reasonable to
assume that there are long-term changes occurring in the brain that support the prolonged
behavioral response known as conditioned defeat. It is already clear that CRF transmission
plays a role in modulating the acquisition and expression of CD, so it is possible that some of
these changes are occurring at the level of CRFRs. The purpose of the current experiment
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was to determine whether there are differences in CRF receptor binding at several timepoints post-defeat in dominant, subordinate, and isolated hamsters, and if those differences
are reflective of changes in CRFR1 or CRFR2 receptor densities.
METHODS
Subjects
Male Syrian hamsters were purchased from Charles River Laboratories.
Experimental animals were three to four months old and weighed 120-140 g at the start of the
study. These animals were individually housed for 10 days to two weeks prior to testing in a
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark
cycle. Older animals that weighed 160-180g were housed individually and used as resident
aggressors for defeats. Younger animals (two months) that weighed 100-110g were grouphoused (five animals per cage) and were used as non-aggressive intruders during social
interaction. All animals were housed in polycarbonate cages (20 x 40 x 20 cm) with corncob
and cotton bedding materials and wire mesh tops. Food and water were available ad libitum.
The cages of experimental animals and resident aggressors were not changed for at least one
week prior to testing to allow the animals to scent mark their territory. All testing and tissue
collection occurred within the first three hours after the onset of the dark phase of the
light:dark cycle in order to minimize circadian variation of the dependent measures. All
experimental animals were handled daily for one week prior to training in order to habituate
them to the stress of being handled by the experimenter. Different groups of hamsters were
used for each experiment. All procedures and protocols were approved by the Georgia State
University Institutional Animal Care and Use Committee.
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Social Interaction
Hamsters were weight-matched into three groups: winners, controls, and defeats.
Social interaction for the winners group consisted of one 15-min interaction with a smaller,
group-housed intruder. The resident-intruder model was chosen over a neutral arena to
increase the chance of attaining each group’s desired outcome, and it most closely resembles
the conditioned defeat model. During the 15-min encounter, the resident experimental
animal attacked the intruder and attained dominance. Social interaction for the defeat group
consisted of one 15-min interaction as an intruder in the cage of a resident aggressor. A
single 15-min social defeat is sufficient to produce CD (Potegal et al., 1993). Treatment for
control animals consisted of being placed in a resident aggressor’s cage alone for 15-min,
during which time the experimental hamster is exposed to the resident aggressor’s bedding
but is not attacked.
Tissue Collection
After behavioral training, animals were sacrificed by rapid decapitation. Weightmatched winner, control, and defeat groups were each divided into two tissue collection
groups. According to group assignment, tissue was collected at either 24 or 72 hours posttraining. 24-hr post-training was chosen because that is when CD is observed, suggesting
that any changes in receptor densities that may occur to support CD may have occurred by
this time point. 72-hr was chosen because CD has been shown to occur up to 33 days postdefeat (Huhman et al., 2003), so long-term changes in receptors may not be evident until a
later time point.
Following decapitation brains were extracted and flash frozen on dry ice before being
stored in a -80°C freezer. Tissue was sliced on a cryostat at 20 µm. Five sets of sequential
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sections targeted at specific points in the brain were collected and mounted on Fisher
Superfrost slides and stored in a -80°C freezer until autoradiography was performed. Two
adjacent sets of sections were processed each for CRFR total binding or CRFR2 binding,
similar to previously described protocols (Sanchez et al., 1999; Lim et al., 2005), and
remaining sets were stained or reserved.
CRF Receptor Autoradiography
Autoradiography procedures were performed similarly to those described previously
(Sanchez et al., 1999; Lim et al., 2005) and are described briefly here. Receptor
autoradiography was performed with [125I-Tyr0]-sauvagine, which has high affinity for both
CRFR1 (Kd=0.2-0.4 nM) and CRFR2 (Kd=0.1-0.3 nM) (Grigoriadis et al., 1996; Primus et
al., 1997). To identify CRFR2 binding sites, [125I-Tyr0]-sauvagine was combined with an
excess of unlabeled CP-154,526, a CRFR1-selective antagonist (Schulz et al., 1996). To
identify CRFR1 binding sites, optical density readings of total CRFR binding minus specific
CRFR2 were used. The subtraction technique is further described below in Data Analysis.
Slides were thawed at room temperature until dry and lightly fixed for 2 min in 0.1%
paraformaldehyde-PBS solution (pH 7.4). Slides were rinsed twice in 50 mM Tris base (pH
7.4) solution for 10 min each, and then incubated in tracer for 60 min. Tracer buffer
consisted of a 50 mM Tris base, 10 mM MgCl, 0.1% bovine serum albumin, 0.05%
bacitracin, plus 0.2 nM [125I-Tyr0]-sauvagine (PerkinElmer/NEN, Boston, MA), which binds
both CRFR1 and CRFR2. Following incubation, slides were rinsed with 50 mM Tris base
plus 10 mM MgCl (pH 7.4) for 3x5 min, plus 30 min with stirring on a stir plate with a
magnetic bar. Slides were then dipped in deionized H2O, blown dry with cool air, and
apposed to Kodak MR film for 72 hr with [125I] microscale standards (PerkinElmer/NEN).
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CRFR2 Autoradiography
An adjacent set of slides were processed at the same time for CRFR2 receptor sites.
CRFR2 binding was measured as described above, with the addition of unlabeled CP154,526-1 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]-pyrimidin-4yl]-ethylamine), a selective CRFR1 antagonist, which was kindly provided by Michael J.
Owens, Ph.D. The concentration of CP-154,526 used in this study was 1 µM, which
competes with [125I-Tyr0]-sauvagine for CRFR1, but not CRFR2, binding sites because the Ki
for inhibition of binding by [125I-Tyr0]-sauvagine to CRFR2 is greater than 10 µM (Schulz et
al., 1996). This protocol has been successfully used to assay rat, hamster, monkey, and vole
tissue (Sanchez et al., 1999; Skelton et al., 2000; Lim et al., 2005).
Data Analysis
Third and fourth sets of adjacent slides were stained for AChE and thionin to better
delineate brain regions (specifically AChE for amygdalar subnuclei) for image analysis.
Total CRFR binding, CRFR2 binding and nonspecific binding were quantified using MCID
Basic v. 7.0 (Imaging Research Inc., Ontario, Canada). AChE- and thionin-stained sections
were used to delineate the borders of brain regions of interest before sampling.
Measurements were averaged for each brain region across two or three sections. Optical
density readings were measured in decompositions per minute per milligram tissue (dpm/mg)
based on a known set of [125I] microscales exposed on each film.
Specific CRFR2 binding values were obtained by subtracting background values from
each section and then nonspecific binding values from [125I-Tyr0]-sauvagine binding in the
presence of 1 µM CP-154,526. Specific CRFR1 binding values were calculated by
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subtracting background values from each section and nonspecific binding, and then
subtracting corrected CRFR2 binding
Statistics
The following equations were used to obtain the corrected values for each CRFR1
and CRFR2: (R2-background)=R2 corrected value; (R1R2-background-R2corrected
value)=R1 corrected value. The corrected values for each region were averaged for each
animal, and an overall mean and standard error was calculated across animals in each group
for each brain region. Means were then compared using a one way analysis of variance.
Alpha was set at 0.05.
RESULTS
The following regions were quantified: lateral septum (LS), posterolateral bed
nucleus of the stria terminalis (BSTPL), lateral amygdala (La), and piriform cortex (Pir). Of
these regions (LS, BSTPL, La, Pir), no significant differences in binding were found
(CRFR1: F(5,47)=0.76), F(5,22)=0.58, F(5,23)=0.22, F(5,23)=0.88, respectively; CRFR2:
F(5,48)=1.09), F(5,23)=1.42, F(5,23)=0.51, F(5,23)=1.04, respectively; p>0.05). Nonstatistical analysis of other brain sites (including periaqueductal gray (PAG) and dorsal raphe
(DR)) revealed no differences in CRFR1 or CRFR2 binding, and no more measurements
were recorded.
DISCUSSION
The current study revealed no differences in CRFR1 or CRFR2 binding between
winners, controls, and defeated hamsters in a number of sites analyzed. The most
parsimonious interpretation of these data is that there are no changes in CRFR1&2 binding
following acute defeat. There are many references to CRF or CRF-like peptide changes
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following various stressors (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998; Hsu et
al., 1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001). On the contrary,
there are fewer examples of changes in receptor binding (see Fuchs and Flugge, 1995).
Although it may be that little research has been dedicated to examining binding sites for
CRF-like peptides following stress, it is possible that this bias in the literature suggests that
changes in peptide availability following stress are more likely to occur than are changes at
the level of CRF receptors.
It is also possible, of course, that CRF receptors are altered by defeat and that the
current design did not reveal this change. While it is possible that there were problems at the
level of the assay performed, it is more likely that the behavioral design was not conducive to
detecting changes. Instead of collecting tissue at time points following the initial defeat, the
tissue could have been collected at various time points following a 5-min CD test (exposure
of a defeated hamster to a non-aggressive intruder). If CRF peptide availability increases in
defeated hamsters, increased CRF peptide release during CD testing might result in
decreased binding of 125I-sauvagine (during autoradiography) compared to controls because
those binding sites are already bound by endogenous CRF.
Although it is possible that an exhaustive analysis of the autoradiography data might
reveal an effect that has not been observed thus far, analysis was focused on limbic sites
previously associated with defeat, particularly the BSTPL (Jasnow et al., 2004b; Cooper and
Huhman, 2005a), and with fear conditioning (LeDoux, 2000; Blair et al., 2001; Repa et al.,
2001), as well as the LS, DR, and PAG, which is associated with defensive behavior. The LS
is involved in the control of agonistic behavior in hamsters (Kollack-Walker et al., 1997;
Delville et al., 2000) and in fear conditioning (Campeau et al., 1997; Vouimba et al., 1998;
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Desmedt et al., 1999; Vouimba et al., 1999; Radulovic et al., 2000). The DR is also involved
in fear circuitry and is a known site for CRF modulation of serotonin (Price et al., 1998;
Kirby et al., 2000; Hammack et al., 2002; Thomas et al., 2003; Waselus et al., 2005).
Finally, the PAG is important for fearful/defensive responses (Misslin, 2003; Vianna and
Brandao, 2003; Vianna et al., 2003). It was expected that any differences in binding between
groups would be evident in one of these sites hypothesized to be important in CD and
dominance/subordinance formation. It is possible that changes may have occurred in a site
we did not anticipate and would only be discovered during an analysis of numerous brain
sites. Though this may be performed at a later date, an analysis of the data at that level is
beyond the scope of this study.
It is more likely, however, that a change in peptide availability and not a change in
available binding sites accounts for defeat-induced behavioral changes mediated by CRF.
This conclusion is drawn from the fact that exogenous CRF administration enhances
submissive behavior in suboptimally defeated hamsters. These hamsters, when given
vehicle, do not show CD, suggesting that changes did not occur following the previous defeat
that could support an alteration in subsequent behavior. However, central administration of
ovine CRF to these hamsters before exposure to a non-aggressive intruder has dramatic
effects on subsequent behavior (i.e., they exhibit high levels of CD). Therefore, it appears
that changes in binding availability may not be occurring following defeat and that increases
in submissiveness are only observed if the quantity of available peptide increases.
Overall, this experiment does not reflect a dead-end but a point at which we can
reconsider potential mechanisms and ways to investigate them. Hopefully, future
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experiments will provide more information toward understanding the role of CRF receptors
in agonistic behavior.
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GENERAL DISCUSSION
Synthesis of the Dissertation
The goal of this project was to investigate the role of CRF type 1 and 2 receptors in
CD and to identify neuroanatomical locations where CRF may be acting. The first study
showed that exogenous administration of a non-specific CRF agonist enhances the
expression of submissive, and possibly aggressive, behavior in hamsters that have previous
social experience. Submissive behavior is increased in hamsters receiving suboptimal (less
than the standard 15-min) defeat training sessions, while aggressive behavior appears to be
increased in hamsters not previously subjected to defeat during the experiment. The second
study aimed to differentiate which receptor subtype, CRFR1 or CRFR2, mediates effects of
r/hCRF on agonistic behavior by giving CRFR subtype-specific agonists before testing. This
study also aimed to further examine effects of CRF on aggressive behavior with additional
control. Further, experiments were performed to determine whether observed effects on
submissive and aggressive behavior were specific to agonistic behavior or if they resulted
from general increases in anxiety-like behavior. The results of this study strongly suggest
that CRFR1 mediates effects of CRF on agonistic behavior, that the effects are modulated by
previous social experience, and that the effects do not appear due to increased anxiety-like
behavior. The third and fourth studies aimed to describe the localization of CRFR subtypes
throughout hamster brain and to determine whether there are social experience-induced
changes in receptor binding of a radiolabeled ligand (possibly indicating increases in binding
availability for endogenous CRF ligands). While we successfully mapped CRFR subtypes
throughout the hamster brain, thereby identifying potential areas of CRFR1 activity related to
agonistic behavior and CD, we did not see changes in receptor binding
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following winning or losing an acute agonistic encounter compared to controls. Though
other possibilities for this lack of change are also proposed in study four, it is suggested that
any changes in CRF neurotransmission are not at the level of the receptor but at the level of
the peptide. This possibility is supported by numerous reviews of stress-induced changes in
CRF peptide or mRNA expression (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998;
Hsu et al., 1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001).
The most important relationship highlighted by these results is that CRFR1 activity
enhances the expression of agonistic behavior and that this increase appears to be modulated
by the animal’s previous social experience. In contrast to this finding, other research in our
laboratory has revealed a relationship between CRFR2 and submissive behavior.
Administration of non-specific or CRFR2-specific antagonists, either ICV or directly into the
BST, attenuate the acquisition and expression of CD while administration of a CRFR1specific antagonist does not (Jasnow et al., 1999; Jasnow et al., 2004b; Cooper and Huhman,
2005a; Cooper and Huhman, 2005b). This seeming contradiction may indeed indicate that
CRFR1 and CRFR2 are involved in different aspects of the learning and the display of
situation-appropriate agonistic behaviors. Because CRFR2 antagonists reduce the acquisition
of CD while neither CRFR1 agonists or antagonists (Jasnow et al., 1999; Cooper and
Huhman, 2005b) affect acquisition, CRFR2 could be involved in memory formation and
retrieval of social defeat. CRFR1 could then be involved in the expression of specific
agonistic behaviors after learning and retrieval have occurred.
The idea that CRFR1 is involved in the output of behavioral responses predetermined
by previous social experience raises questions about where and how CRFR1 is affecting the
expression of agonistic behavior. While it is not possible with the current data to outline
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specific pathways and mechanisms involved, examining the distribution of CRFR1 in the
context of the neural control of agonistic behavior suggests possible directions for further
investigation. The first question to address is at what point in the expression of agonistic
behavior CRFR1 might be playing a role. Siegel et al. (1999) proposed two classes of
pathways involved in the “attack response” that may be applicable to this discussion. The
first pathway is involved in “mediating expression,” that is, acting at the level of neural
signals necessary for carrying out motor and autonomic responses. The second pathway is
involved in “modulating expression,” or modulating a “threshold” for eliciting the expression
of agonistic behavior (i.e., suppression or facilitation of behavioral output). If CRFR1 are
involved at the level of “mediating expression,” then blocking CRFR1 should block the
expression of agonistic behavior. However, this role is not likely because administration of
the CRFR1-specific antagonist CP-154,526 does not affect CD (Jasnow et al., 1999; Cooper
and Huhman, 2005b). A more likely role for CRFR1 lies at the level of “modulating
expression” of agonistic behavior by affecting “thresholds,” via some unknown pathway,
necessary for the display of agonistic behavior. Because oCRF (a CRFR1-specific agonist)
increases agonistic behavior in suboptimally defeated hamsters, it is possible that the
concomitant increase of CRFR1 activity is occurring at the level of this/these unspecified
“threshold(s).” By doing so, oCRF may be facilitating the attainment of a necessary
threshold for initiating the expression of agonistic behavior. On the other hand, CRFR1
antagonists have no effect on the expression of submissive behavior in optimally (15-min)
defeated hamsters. It is possible that these hamsters have undergone changes at this
“threshold” level or at a level downstream of this point such that CRFR1 activity is no longer
necessary to elicit the expression of agonistic behavior.
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Although it is not clear where CRFR1 activation is occurring to affect agonistic
behavior, the idea that CRFR1 is modulating the expression of agonistic behavior (as
discussed above) helps to narrow the list of potential sites of action. According to Siegel et
al. (1999), the location where “modulation of expression” occurs is likely to be limbic. Of
the limbic sites thought to be involved in aggressive and defensive behavior in hamsters, the
LS shares reciprocal connections with the AH (the latter is considered the center of the neural
network controlling offensive aggression in hamsters and in other species; Albert and Walsh,
1984; Siegel et al., 1999; Delville et al., 2000) and shows increases in c-fos mRNA following
acute defeat (Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997).
Additionally, CRFR1 binding was observed in the LS in the current study, confirming the
existence of CRFR1 in this structure. Thus, the LS is a possible site of action for CRFR1
binding in enhancing agonistic behavior. Perhaps the LS is exerting inhibitory control on
aggressive behavior that is enhanced by CRFR1 binding in previously defeated hamsters,
thereby facilitating the suppression of aggressive behaviors to allow for enhanced expression
of defensive behavior. On the other hand, CRFR1 binding may be lower in hamsters that
have not been defeated, thereby facilitating the expression of aggressive behavior.
Another limbic site involved in both aggressive and defensive behaviors is the BST.
Acutely defeated hamsters express increases in c-fos mRNA in the BST (Kollack-Walker and
Newman, 1995; Kollack-Walker et al., 1997), which, like the LS, shares reciprocal
connections with the AH (Delville et al., 2000). The BST also expresses c-fos
immunolabeling following a display of offensive aggression (specifically in the
posteromedial division of the BST; Delville et al., 2000). Because CRFR1 are expressed
throughout the BST in hamster, the BST may be another possible site of CRFR1 activity
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involved in enhancing agonistic behavior. Presently, it is difficult to propose a mechanism
for these actions. However, the reciprocal connections between the BST and AH enter the
posterior BST, and c-fos immunolabeling after offensive aggression occurs in the BSTPM
(Delville et al., 2000). Additionally, increases in c-fos mRNA expression following acute
defeat occur in the BSTA. It is therefore possible that the BSTPM and BSTA are potential
sites of CRFR1 binding for enhancing aggressive or defensive behavior, respectively.
It is likely that there are other possible sites of action, or different sites for particular
aggressive and defensive behaviors, where CRFR1 activity can alter agonistic behavior in a
modulatory fashion. However, these hypotheses allow for continued investigation of this
phenomenon in an effort to further examine the role of CRFR1 in the enhancement of
agonistic behavior.
Future Directions
The LS is the most straightforward place to begin an investigation of other limbic
sites that may mediate the effects of CRFR1 activation on agonistic behavior. Similar to the
experimental design used in the agonist studies in the current project, hamsters could be
implanted with a guide cannula into the LV and the LS. By injecting a CRFR1 antagonist
(like CP-154,526) into the LS prior to ICV injection of oCRF, CRFR1 in the LS should be
effectively blocked by the antagonist, preventing binding of oCRF. If the LS is the site
where CRFR1 activation is occurring to enhance agonistic behavior, enhancement should not
occur in hamsters receiving CP-154,526. Figure 1 of the Appendix proposes potential
pathways that originate in the LS.
Assuming the LS is the site of CRFR1 activation, its reciprocal connections with the
AH would provide a pathway for the enhancement of aggressive behavior. It is possible that
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inhibitory control of aggressive behavior from the LS to the AH may be “turned off,” or
inhibited, by CRFR1 activation in the LS in animals that have not been previously defeated.
In this way, aggressive behavior is not being suppressed (and may actually be increased).
Conversely, CRFR1 activation in a previously defeated hamster may facilitate inhibition of
aggression through LSÆAH connections, decreasing the likelihood of displaying aggressive
behavior. Assuming the enhancing effects of CRFR1 activity on aggressive and submissive
behavior are occurring via the same site of action, it is possible that connections from the LS
to the AH also activate mechanisms that initiate defensive behavior. This idea is supported
by the fact that c-fos mRNA increases in the AH in hamsters following acute defeat
(Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997). Alternatively, another
possible pathway for activating defensive behavior could be through LSÆ extended
amygdala connections. In particular, the Ce or BSTL, both of which are involved in
initiation of autonomic and endocrine responses to stress, may be important for activating
defensive behavior. As it is difficult to differentiate brain regions involved in stress
responding from specific regions involved only in defensive behavior (Kollack-Walker and
Newman, 1995; Kollack-Walker et al., 1997), it is likely that defensive behavior in
submissive hamsters is modulated by the same upstream sites that are stimulating the
accompanying stress response. Potential candidates include Ce, BSTPL, IL, LS, and DR.
These sites provide potential targets to further map out the circuitry controlling the effect of
CRFR1 activation on agonistic behavior. Finally, once it is determined to where the LS is
projecting to affect agonistic behavior, it will be necessary to determine, on a molecular
level, how CRFR1 binding is activating these pathways and how previous social experience
is modulating its effects.
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A similar experimental design to that described above could be applied to
investigation of the BST in mediating the effects of CRFR1 activation on agonistic behavior.
However, this approach is complicated by the fact that CRFR1 activity could be occurring in
discreet, and possibly multiple, subdivisions of the BST to enhance the experienceappropriate behavior. Connections between the BSTP and AH could mediate enhancement
of aggressive behavior in hamsters that have not been previously defeated. If so, the
enhancement of aggressive behavior may be blocked by CP-154,526 injection into the
BSTPM prior to ICV injection of oCRF. Investigating the site of action of CRFR1 activation
on defensive (or submissive) behavior is more complicated. Increased c-fos mRNA
expression has been observed in the BSTA following defeat, making this site a possible
candidate for oCRF binding. However, because defensive behavior and stress response
circuitry are likely overlapping, the BSTPL may be a possible site of action due to its
connections to the stress system (Walker and Davis, 1997; Davis et al., 1997; Davis and Shi,
1999; Lang et al., 2000). Therefore, both the BSTPL and the BSTA (specific anterior
subdivision unknown) are candidates for receiving CP-154,526 prior to ICV oCRF. Figure 2
of the Appendix proposes potential pathways that originate in the BST. If antagonism of
CRFR1 in one of these sites blocks enhancement of submissive behavior by oCRF in
previously defeated hamsters, further investigation can commence as to the specific
molecular mechanisms involved in this effect and how previous social experience modulates
this outcome. In the event that antagonism of CRFR1 in both BSTA and BSTPL block
enhancement of submissive behavior, it is possible that there are connections from or
between these two sites that are involved in the control of this effect.
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As stated previously, these are only starting points for further investigation. Despite
the numerous findings of this project, an understanding of CRF enhancement of agonistic
behavior is far from being attained. I have essentially come a long way to know virtually
nothing about this phenomenon, but I look forward to the challenge of one day answering
these questions.
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Figure A.1. Represents potential circuitry involved in the control of agonistic behavior by
CRFR1 in the LS. In non-defeated hamsters, CRFR1 activity blocks the inhibitory control of
the LS over the AH, which allows for the expression of aggressive behavior. Conversely, in
previously defeated hamsters, CRFR1 in the LS results in inhibition of aggressive behavior
by inhibiting the AH. Additionally, projections from the LS to stress circuitry (such as the
extended amygdala and other sites) would likely mediate the effects of CRFR1 on defensive
behavior (these projections may be direct or indirect).
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Figure A.2. Represents potential circuitry involved in the control of agonistic behavior by
CRFR1 in the BST. In previously defeated hamsters, CRFR1 activation could be occurring
in the BSTPL, initiating stress-responsive behavior (including defensive behavior). In nondefeated hamsters, CRFR1 activity could be occurring in the BSTPM, and projections to the
AH would then initiate aggressive behavior. Another possibility for the initiation of
agonistic behavior in defeated hamsters is that CRFR1 binding is occurring in the BSTA,
which may have projections to the appropriate subregions of the BSTP to block aggressive
behavior in previously defeated hamsters while indirectly activating defensive behavior via
the BSTPL (or the BSTPL may be directly activated by concomitant binding at CRFR1 in
that subregion).
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